TSS:Rfhg 151697.1

Basic information about the TSS

---

TSS ID: rfhg_151697.1 TSS ID(Version3): hg_125972.1 hg_125971.1 Species: human Chr: chr12		Start: 55716027 End: 55716114 Strand: +
Source datasets	FANTOM5|PRJNA401781|PRJNA615891|PRJNA548673|PRJNA597322 |PRJDB5282|PRJNA4843412|DRA013844
Protocol	CAGE|oligo_capping|TIF-seq2|ReCappable-seq|RAMPAGE |SLIC_CAGE|STRIPE-seq|C1CAGE|NETCAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2563020,EH38E1615133)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000548925.5:0 ENST00000549147.1:0 ENST00000553100.1:0 D64007:0 AK307069:0 BC066340:0 BC130640:0 BC132795:0 S82447:0 GeneID: 2647 HGNC/MGI_ID: HGNC:4200 UniProt_ID: F8VP73 H0YHA4 P78537 Nearer transcript ids and distances: KJ901448:19 AB527695:20 ENST00000547076.5:178 NR_037657.2:357 NR_037656.2:357 ENST00000551926.1:399 ENST00000548556.1:417 ENST00000549424.1:476 view more...

Gene_name: biogenesis of lysosomal organelles complex 1 subunit 1 Gene_symbol: BLOC1S1 Gene_synonyms: BLOS1 BORCS1 Gene_source: HGNC:4200

TATA-Box annotation

---

Distance to TSS:	36
Nearest PromoterID:	NR_037658
Entrez ID:	100528022
Nearest Unigene:	Hs.600940
Nearest Refseq:	NR_037658
Nearest Ensembl:
Gene Name:	biogenesis of lysosomal organelles complex 1 subunit 1
Gene Alias:	-
Gene Type:	ncRNA
CpG%:	0.114943
GC%:	0.715909
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@BLOC1S1 p2@BLOC1S1 p3@BLOC1S1 p4@BLOC1S1 p5@BLOC1S1 p6@BLOC1S1 p8@BLOC1S1
Sample		p1@BLOC1S1	p2@BLOC1S1	p3@BLOC1S1	p4@BLOC1S1	p5@BLOC1S1	p6@BLOC1S1	p8@BLOC1S1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.60	7.60	1.75	1.17	0.78	0.58	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	22.46	8.09	1.42	0.81	1.01	0.61	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	26.43	8.87	1.16	1.16	0.96	0.58	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	24.12	5.61	1.04	0.83	0.42	0.21	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	22.05	7.87	2.70	0.67	0.90	0.45	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	20.16	7.75	1.74	0.39	0.58	0.78	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	29.20	11.98	1.31	1.53	0.44	0.87	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	25.19	6.54	1.45	1.21	0.97	0.73	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	27.14	9.83	1.92	0.64	0.64	0.85	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	17.97	5.80	1.16	0.58	0.58	1.74	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.55	3.23	1.21	0.81	0.00	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.64	3.25	2.03	0.41	0.00	1.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	30.79	5.64	0.97	2.58	0.64	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.52	4.81	0.75	1.95	1.05	0.75	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	27.01	5.49	0.44	1.76	0.88	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	26.16	5.78	1.01	1.26	1.01	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	27.96	4.80	1.09	1.09	0.00	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	27.42	5.91	1.69	1.27	0.42	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.06	5.33	0.53	1.60	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	30.39	4.36	1.65	3.46	1.35	1.05	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.08	3.74	1.07	1.34	0.80	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	30.73	5.18	1.38	1.90	1.04	0.86	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	29.21	4.91	2.07	1.81	0.26	0.90	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	25.72	5.82	1.21	1.21	0.00	0.73	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	26.06	4.39	1.29	2.32	0.52	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	28.49	6.65	0.95	1.58	0.32	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	26.37	6.59	0.00	4.95	0.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	37.48	5.89	1.18	2.12	0.94	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	30.85	6.30	0.32	2.10	0.48	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	36.56	5.79	0.90	1.81	1.09	1.45	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	32.45	5.23	0.42	2.30	1.47	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	25.01	5.86	1.37	1.37	0.78	0.78	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	34.19	5.06	0.42	2.11	1.06	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	40.91	7.59	0.49	2.97	0.99	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	30.48	7.11	0.93	0.93	0.93	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	25.29	4.79	0.96	0.77	0.77	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	34.13	4.70	1.64	1.02	0.61	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	29.62	5.24	1.01	1.01	2.42	0.81	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	33.49	7.83	0.81	1.35	1.35	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	31.45	7.68	0.96	1.44	0.48	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	30.35	6.12	2.12	1.41	0.24	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	28.99	6.29	1.76	1.76	0.29	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	27.63	5.48	0.84	1.05	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	24.83	3.85	0.17	1.57	0.35	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	27.71	5.62	1.20	1.61	1.41	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	29.78	4.19	1.16	1.63	0.23	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	25.67	3.84	0.72	1.20	0.72	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	28.31	4.17	0.60	2.38	1.19	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	25.61	5.03	0.24	0.72	0.96	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	29.32	6.07	1.21	1.62	0.40	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	27.26	3.69	0.00	1.23	1.02	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	27.57	3.56	0.89	1.11	0.22	0.67	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	26.26	2.13	0.00	1.42	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.21	1.99	0.99	0.33	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	44.46	6.71	0.84	6.71	5.03	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	27.55	4.13	0.46	1.38	0.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.34	1.30	0.65	0.00	0.97	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.27	0.96	0.32	0.96	0.64	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	30.49	4.71	0.63	1.57	1.26	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	13.40	1.41	1.41	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	13.46	2.80	1.12	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	22.29	2.39	0.00	0.00	0.80	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	21.41	1.70	0.00	0.00	0.34	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.02	1.95	0.00	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	17.39	1.06	0.35	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	39.49	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	19.50	0.49	0.00	0.49	0.00	0.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	21.82	1.98	0.99	0.50	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	19.70	1.88	0.00	0.00	0.47	1.88	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	24.51	1.66	0.33	0.66	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	19.18	3.40	0.00	1.24	0.93	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	21.10	3.67	1.22	0.00	0.31	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	65.10	7.76	0.16	1.27	1.11	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	52.78	7.22	0.16	0.96	1.60	0.00	0.16
Adipocyte - omental, donor1	11473-119C6	48.73	7.25	0.00	1.78	1.27	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	102.41	5.98	0.00	0.00	2.24	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	76.03	15.41	1.00	1.34	3.01	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	88.04	15.95	0.64	0.00	2.55	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	70.37	15.39	0.00	3.30	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	44.26	4.52	1.35	0.45	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	48.31	8.34	0.35	5.04	1.56	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	40.87	6.85	0.59	2.15	0.98	0.20	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	47.36	2.06	0.77	1.29	0.26	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	50.46	5.58	1.12	0.84	1.67	0.28	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	49.96	8.23	1.18	1.76	1.18	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	54.13	5.31	0.56	1.05	0.08	0.24	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	54.55	4.84	0.65	0.65	0.65	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	31.46	4.80	1.07	0.53	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	55.64	6.68	0.00	2.23	2.23	0.56	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	90.25	10.40	3.33	2.50	2.08	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	61.03	5.02	0.25	1.00	0.75	0.50	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	58.90	4.91	0.00	0.33	0.33	0.00	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	54.50	3.96	0.91	0.00	0.61	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	57.24	6.19	2.87	0.44	0.88	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	83.19	12.91	2.51	0.00	0.36	1.43	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	29.95	7.19	1.20	0.00	2.40	1.20	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	42.10	9.36	1.26	0.72	1.26	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	61.92	8.37	5.02	1.67	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	52.59	14.18	1.44	1.44	1.44	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	70.83	16.71	2.52	4.69	2.75	1.60	0.00
Anulus Pulposus Cell, donor2	11463-119B5	71.02	16.16	4.41	0.98	2.69	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	80.42	16.62	0.45	1.35	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	85.09	10.85	0.87	3.47	0.87	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	36.38	14.98	0.00	4.28	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	86.69	11.96	0.60	1.20	2.09	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	99.91	22.76	1.26	0.00	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	52.81	8.58	0.66	1.98	1.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	72.45	10.40	0.00	3.25	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	92.72	14.56	0.00	0.97	1.94	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	51.07	11.88	0.59	2.97	1.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	88.13	13.18	0.75	1.51	3.77	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	79.10	8.71	0.00	1.45	1.45	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	52.66	13.79	1.25	0.00	2.51	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	67.21	11.53	0.33	1.65	2.31	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	92.81	16.38	0.00	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	57.15	6.94	0.60	1.51	0.75	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	77.69	11.79	1.07	1.61	1.07	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	76.33	8.88	0.76	1.32	0.76	0.00	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	49.98	7.22	0.80	0.80	0.80	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	85.84	11.71	0.00	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	69.16	10.45	0.83	1.33	0.83	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	32.42	9.61	0.00	4.80	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	53.10	10.62	3.54	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	63.29	8.75	0.51	1.37	0.86	0.17	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	33.56	12.58	0.00	4.19	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	83.01	15.05	1.94	2.91	2.43	0.49	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	84.24	10.62	1.14	0.76	1.14	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	56.93	9.69	0.00	0.00	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	93.49	9.12	0.57	2.28	2.85	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	65.42	8.98	0.86	1.07	1.28	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	60.91	10.32	0.00	2.84	1.29	0.26	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	91.03	14.55	1.41	0.94	1.41	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	63.99	8.04	0.64	0.64	0.64	0.00	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	71.35	7.85	0.71	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	62.00	11.70	0.00	0.58	1.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	64.13	9.63	0.60	1.20	1.81	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	70.09	11.88	0.00	3.56	2.38	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	97.13	17.80	0.00	4.07	2.03	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	75.39	10.70	0.51	1.27	1.27	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	76.88	7.62	0.00	0.64	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	78.11	11.65	0.43	2.59	2.59	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	71.55	10.37	1.48	0.85	1.91	0.64	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	54.52	6.09	0.29	1.45	0.87	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	66.13	17.01	0.00	0.94	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	74.93	13.39	0.85	1.53	1.19	0.17	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	55.59	6.95	0.00	0.00	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	76.05	8.45	0.00	6.34	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	79.98	10.29	0.86	1.29	2.14	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	55.35	6.62	0.60	2.41	1.80	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	69.25	13.85	2.19	2.19	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	77.70	10.11	0.92	2.30	2.30	0.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	56.11	12.75	0.00	0.00	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	60.51	7.88	0.51	2.29	2.03	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	62.55	9.70	1.03	1.45	1.45	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	60.59	7.04	0.61	1.53	0.31	0.61	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	89.87	17.69	0.00	3.35	2.87	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	58.76	7.32	0.44	1.55	1.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	56.45	7.63	0.00	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	83.08	8.31	0.55	0.00	0.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	55.34	10.06	1.32	0.79	0.53	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	56.33	8.36	1.82	1.82	0.00	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	70.01	23.09	2.70	1.72	3.07	2.46	0.00
Astrocyte - cerebellum, donor2	11580-120F5	80.27	26.19	3.42	2.57	5.13	1.71	0.00
Astrocyte - cerebellum, donor3	11661-122F5	48.24	14.05	1.68	2.73	3.36	1.47	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	72.16	14.64	2.44	2.44	2.09	2.44	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	44.49	13.75	3.07	3.07	1.94	2.91	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	52.95	15.81	3.43	2.54	2.24	4.33	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	39.11	11.01	2.98	2.41	1.72	3.78	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	42.35	9.90	3.51	1.75	1.38	4.13	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	39.60	9.45	3.53	2.50	1.25	3.87	0.00
Basophils, donor1	12241-129G9	71.14	3.92	0.52	0.78	0.26	0.26	0.00
Basophils, donor2	12242-129H1	48.35	5.05	1.44	1.80	0.00	0.00	0.00
Basophils, donor3	12243-129H2	39.40	2.65	0.59	0.15	0.15	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	29.32	3.23	0.86	0.00	0.86	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	55.78	8.23	5.94	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	7.17	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	46.45	9.41	6.90	1.26	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	36.18	5.20	3.12	0.62	0.42	1.04	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	24.18	5.30	1.84	0.23	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	25.73	5.94	1.98	1.08	0.00	0.36	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	55.75	17.93	8.14	6.08	1.85	3.19	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	33.77	12.58	5.36	2.79	1.63	1.40	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	112.56	15.99	4.80	3.52	2.88	0.64	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	103.42	31.03	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	55.23	1.69	1.13	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	48.63	2.23	0.56	0.19	0.19	0.37	0.00
CD14+ Monocytes, donor3	11381-118B4	50.71	2.63	0.44	0.00	0.66	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	198.13	9.62	0.00	1.70	1.98	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	144.81	7.96	1.52	0.76	2.27	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	166.01	9.20	0.66	0.33	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	107.54	8.82	1.16	1.88	0.87	0.87	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	61.25	5.43	0.91	2.41	0.30	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	76.28	4.50	0.24	0.24	0.71	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	89.22	6.03	1.84	1.00	0.84	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.58	3.86	0.28	0.00	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	68.18	4.71	1.24	1.24	0.25	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	97.90	7.83	1.76	0.59	0.39	0.78	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	67.84	5.52	1.25	0.53	0.53	1.25	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	107.51	5.88	0.87	1.31	0.87	0.65	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	70.47	3.98	0.70	0.23	0.23	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	41.19	1.58	0.00	0.53	0.53	0.53	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	59.91	2.22	0.00	2.22	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	90.74	5.95	1.64	1.64	0.89	0.74	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	55.47	3.99	0.80	0.60	0.20	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	91.61	5.20	1.25	1.04	0.62	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	96.55	9.84	0.46	0.92	0.23	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	54.06	1.81	0.45	0.90	0.00	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	43.21	3.49	0.00	0.87	0.00	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	102.22	6.19	0.81	0.00	0.54	0.81	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	89.32	6.98	2.09	1.74	0.35	0.70	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	103.94	2.52	1.26	2.10	0.42	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	86.71	6.25	0.55	0.92	0.73	0.55	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	47.91	1.76	0.35	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	57.03	3.07	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	98.00	10.64	2.44	1.22	0.70	1.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	75.08	4.09	0.74	1.12	0.74	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	113.59	6.90	1.94	2.37	0.22	0.86	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	68.38	4.09	0.41	0.41	1.23	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	48.45	3.94	1.39	0.93	0.23	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	60.78	3.48	0.46	1.16	0.93	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	184.62	9.37	0.22	1.31	1.31	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	179.25	7.39	0.92	2.54	1.39	0.23	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	175.24	9.10	0.65	0.87	0.43	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	170.83	7.47	1.25	1.09	0.78	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	144.61	3.67	1.40	0.35	0.52	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	154.07	4.01	1.34	0.89	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	312.33	18.12	2.04	3.06	2.30	1.28	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	244.38	9.44	1.32	2.63	1.98	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	225.92	9.05	0.42	0.42	2.11	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	209.33	18.29	2.03	2.03	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	147.12	29.15	0.00	2.71	1.36	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	160.52	21.75	1.04	1.04	1.04	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	139.66	20.79	1.60	1.60	1.07	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	199.42	40.74	1.07	1.07	5.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	150.21	18.25	0.70	3.51	0.70	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	181.97	21.18	0.00	2.35	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	222.79	29.00	2.64	0.00	3.95	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	58.35	8.22	0.00	2.47	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	45.70	7.98	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	40.39	10.10	0.50	1.51	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	289.71	5.66	4.04	0.81	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	305.21	3.60	2.80	0.80	0.80	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	54.22	4.02	3.01	1.00	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	52.25	10.67	0.56	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	116.48	11.27	4.51	1.50	1.50	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	144.53	18.49	4.74	1.80	2.48	0.68	0.00
CD4+ T Cells, donor1	11225-116C1	36.06	3.57	0.36	0.36	0.36	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	39.80	4.29	0.00	1.22	0.61	0.61	0.00
CD4+ T Cells, donor3	11382-118B5	42.70	7.01	0.30	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	95.46	20.67	2.30	1.28	0.26	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	75.46	11.01	1.35	1.35	0.22	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	66.12	10.35	1.15	0.86	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	95.77	18.02	0.47	0.95	0.95	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	107.46	14.05	2.11	0.00	0.70	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	75.81	3.30	0.00	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	89.17	16.33	2.46	1.73	1.16	0.58	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	85.24	10.00	3.73	1.19	1.02	1.53	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	67.55	9.51	2.58	1.13	1.61	0.48	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	99.52	12.55	2.69	1.79	0.90	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	120.89	13.98	1.75	1.05	1.05	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	86.24	11.88	0.88	1.32	1.32	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	93.18	19.40	0.84	1.69	2.11	0.84	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	90.59	13.09	4.99	2.70	1.45	0.83	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	93.56	17.71	5.01	2.67	1.67	1.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	70.70	8.16	0.82	1.09	0.27	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	74.50	9.65	0.00	1.61	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	69.94	12.55	0.00	1.79	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	120.71	19.28	5.93	1.48	1.48	1.48	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	116.97	16.68	4.12	1.73	0.00	1.73	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	124.62	16.39	5.46	0.84	1.05	0.84	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	126.91	17.19	1.01	1.01	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	113.95	17.76	0.00	0.43	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	77.58	7.41	0.44	0.44	0.44	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	156.38	20.78	0.99	1.98	0.99	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	175.41	23.08	0.92	1.85	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	196.81	20.94	4.19	1.40	5.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	193.30	18.00	1.94	0.55	1.66	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	199.75	23.31	1.47	0.98	0.98	0.74	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	127.82	12.32	0.00	0.00	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	165.81	18.26	1.79	2.15	0.36	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	235.45	23.54	0.00	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	38.96	3.93	0.00	0.00	0.98	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	42.80	5.26	0.75	0.75	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	44.44	4.04	0.25	1.26	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.86	3.44	2.06	0.92	0.69	2.06	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	19.41	3.59	1.44	0.24	0.96	2.88	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	17.24	7.11	1.37	0.00	0.00	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	24.62	7.51	1.80	1.50	0.30	1.80	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	25.44	5.04	0.24	0.00	0.24	1.44	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	22.97	3.87	2.27	0.91	0.45	0.68	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	25.86	4.13	2.17	0.65	1.09	1.30	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	24.74	5.79	1.84	0.79	1.05	1.05	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	29.31	6.80	0.94	0.23	0.00	0.70	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	26.57	6.04	3.32	0.91	0.60	0.91	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	27.60	3.78	2.91	0.58	0.87	1.16	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.91	6.66	4.00	2.40	0.53	2.13	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	14.88	5.25	0.88	0.00	0.44	0.88	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	11.39	2.73	2.28	0.00	0.46	0.91	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	13.43	1.49	3.73	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.41	3.60	1.80	1.08	0.72	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	26.18	4.03	1.15	0.00	0.29	2.01	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	19.80	2.36	1.18	0.24	0.71	0.71	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	26.30	3.17	0.95	1.58	0.32	0.95	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	23.37	3.69	0.62	0.92	0.31	0.31	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	19.56	3.85	1.28	0.32	0.96	0.96	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	25.24	4.97	2.29	0.76	0.76	2.29	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	25.22	3.55	3.55	0.00	0.39	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	19.67	0.76	2.27	0.00	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	15.26	2.41	0.80	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	6.99	2.10	2.10	0.00	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	9.02	1.00	1.00	0.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	40.21	7.31	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	66.70	9.88	0.99	1.98	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	43.04	9.16	0.84	0.84	0.84	0.53	0.11
Chondrocyte - de diff, donor1	11261-116G1	65.17	11.09	1.04	1.39	1.73	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	62.90	13.86	2.49	0.36	2.13	0.71	0.71
Chondrocyte - de diff, donor3	11410-118E6	72.25	13.08	1.14	3.41	2.16	0.80	0.34
Chondrocyte - re diff, donor2	11339-117F7	75.20	14.32	0.90	0.90	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	47.72	8.09	0.40	0.81	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	42.80	15.15	2.18	9.30	3.21	5.16	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	31.64	15.60	1.71	2.78	3.85	1.07	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	40.09	15.84	1.50	4.78	3.19	2.30	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	72.08	7.79	1.10	0.73	0.92	0.55	0.00
Corneal Epithelial Cells, donor1	11526-119I5	31.84	6.81	3.51	0.66	1.54	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	19.34	9.10	5.69	2.28	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	33.49	12.53	2.56	2.05	1.79	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	102.36	4.29	0.66	0.17	0.66	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	121.12	7.25	1.89	1.58	0.32	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	151.83	10.35	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	124.94	7.56	0.65	0.65	0.43	0.22	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	29.72	1.37	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	58.76	1.96	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	48.39	1.45	0.00	0.00	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	45.69	6.17	1.50	1.00	0.00	0.50	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	56.92	4.11	2.93	1.76	1.17	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	44.40	11.59	1.41	0.57	0.28	1.41	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	46.79	8.26	0.79	1.57	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	54.10	11.34	0.58	0.29	2.33	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	33.88	12.47	2.35	0.24	0.94	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	46.46	9.29	0.88	0.88	1.05	0.18	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	35.02	5.76	0.66	0.66	0.44	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	32.86	4.26	0.00	0.91	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.04	8.46	0.56	0.28	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	64.48	9.81	2.67	0.59	0.30	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	47.90	12.50	1.04	1.04	0.52	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	34.31	8.22	1.70	1.28	1.99	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	56.42	10.80	1.60	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	58.70	5.77	2.10	0.00	1.05	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	40.13	9.82	2.48	1.62	0.87	0.25	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	37.15	10.43	3.69	1.52	1.09	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	38.35	8.55	2.56	1.34	1.47	0.73	0.00
Endothelial Cells - Vein, donor1	11267-116G7	63.70	14.79	2.28	5.69	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	35.62	7.68	0.70	0.00	1.40	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	53.54	10.21	1.41	1.10	0.94	0.63	0.00
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	156.77	8.25	0.00	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	167.64	7.13	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	30.05	5.86	3.42	0.49	0.98	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	8.32	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	41.87	8.21	0.41	2.05	2.87	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	47.52	5.91	0.22	3.61	2.41	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	65.54	10.94	1.41	2.71	3.36	0.54	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	42.81	7.76	0.73	3.40	1.58	1.33	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	25.66	2.87	0.41	0.68	1.09	0.68	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	48.30	7.70	0.84	2.00	1.69	0.32	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.40	5.53	0.00	0.53	0.00	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	52.49	10.30	1.00	2.99	0.66	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	68.04	12.70	0.45	2.27	0.91	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	32.59	5.31	2.27	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	65.61	9.15	1.89	0.63	1.42	0.16	0.00
Fibroblast - Cardiac, donor4	11452-119A3	40.62	7.58	0.30	0.30	0.61	1.21	0.00
Fibroblast - Cardiac, donor5	11456-119A7	45.81	10.28	0.63	0.63	1.52	0.13	0.00
Fibroblast - Cardiac, donor6	11460-119B2	49.12	9.55	2.43	0.91	1.36	0.61	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	53.73	19.29	0.54	2.41	2.28	0.40	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	41.85	19.41	0.43	3.45	1.73	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	29.30	8.79	2.93	1.46	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	55.58	14.30	6.00	2.08	2.08	1.85	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	55.12	10.85	1.19	4.24	1.36	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	37.33	4.46	1.41	2.82	1.17	0.70	0.00
Fibroblast - Dermal, donor2	11346-117G5	64.62	4.72	1.42	1.42	0.94	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	51.13	9.43	1.93	3.14	2.06	0.85	0.12
Fibroblast - Dermal, donor4	11450-119A1	43.86	12.10	4.52	1.92	0.79	1.81	0.00
Fibroblast - Dermal, donor5	11454-119A5	50.94	13.78	2.62	1.74	1.40	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	61.40	13.48	3.25	1.95	2.11	2.27	0.00
Fibroblast - Gingival, donor1	11237-116D4	41.44	7.50	2.29	2.71	1.04	1.04	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	70.22	9.69	1.05	2.10	3.14	0.52	0.00
Fibroblast - Gingival, donor2	11318-117D4	49.29	12.78	1.98	2.77	1.58	1.32	0.00
Fibroblast - Gingival, donor3	11394-118C8	39.54	10.44	1.74	1.93	1.16	0.29	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	65.45	11.43	2.08	2.08	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	49.87	13.22	1.06	2.82	0.70	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	72.02	11.85	2.81	2.49	2.03	2.34	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	58.82	13.52	2.30	3.38	2.98	2.16	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	29.64	4.59	1.06	0.71	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	75.75	9.07	1.90	3.07	3.22	0.73	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	55.77	9.27	2.05	4.50	3.41	0.95	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	51.78	9.65	1.65	2.96	2.52	1.43	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	67.50	9.98	0.29	2.64	2.20	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	57.09	10.87	1.36	1.36	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	43.27	10.45	1.49	2.98	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	79.56	15.41	2.53	1.27	1.27	2.11	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	84.14	5.00	0.83	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	67.13	4.20	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	51.78	5.32	0.56	0.28	1.96	0.28	0.28
Fibroblast - Mammary, donor1	11540-120B1	70.64	7.71	1.62	2.84	1.22	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	67.90	7.99	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	47.65	11.91	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	57.22	11.44	4.07	2.91	1.94	3.30	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	42.77	10.01	4.55	3.03	0.91	0.91	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	34.27	4.90	0.92	0.31	0.00	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	88.54	15.26	1.53	4.20	2.67	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	81.81	17.01	2.43	3.51	3.24	2.43	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	65.06	11.13	0.93	2.20	2.09	0.46	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	57.03	9.51	1.55	1.77	1.99	0.33	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	69.49	5.08	1.42	0.61	0.20	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	54.79	18.04	0.67	2.67	4.68	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	59.30	17.40	2.77	7.12	3.95	1.19	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	25.80	3.37	0.60	0.79	0.60	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	63.94	10.48	0.89	2.13	2.13	0.00	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	54.79	8.47	0.79	2.76	0.99	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	37.31	6.32	2.71	0.60	0.90	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	89.49	13.17	0.86	1.30	1.73	0.43	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	46.82	6.83	0.00	1.01	1.52	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	77.94	8.04	0.98	1.64	1.15	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	23.46	4.21	0.80	1.60	0.60	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	76.15	9.44	0.70	0.90	0.70	0.30	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	36.27	7.25	1.21	0.30	1.81	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	61.89	9.86	0.75	2.90	0.91	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	64.45	13.16	2.22	1.37	1.03	0.51	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	31.86	6.90	0.66	0.33	1.64	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	87.56	10.55	1.28	1.17	1.28	0.64	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	64.44	9.11	1.86	3.04	0.51	0.51	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	84.37	14.74	0.94	4.70	2.82	0.47	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	177.28	22.16	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	46.19	3.49	0.87	0.87	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	41.95	4.68	0.52	0.35	0.35	0.52	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	30.45	4.42	1.56	0.52	0.26	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	32.45	5.62	0.26	0.77	1.02	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	35.22	21.44	8.42	6.89	1.53	6.89	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	32.54	21.06	10.85	7.66	3.83	5.74	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	58.19	29.38	10.27	9.41	4.56	4.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	39.43	11.58	7.72	6.62	1.93	4.41	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	31.28	11.64	5.02	5.71	2.51	2.97	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	40.62	27.34	6.93	6.14	1.59	3.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.44	11.37	8.19	2.64	1.06	3.44	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	36.20	12.39	2.61	5.87	1.63	3.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	37.15	23.44	5.75	5.75	2.65	5.75	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	41.55	16.11	6.78	4.10	2.12	1.70	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	39.65	16.75	3.94	4.43	0.99	1.60	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	33.85	20.15	3.49	3.22	1.88	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.29	14.99	2.35	2.23	0.50	1.86	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	42.91	15.37	3.74	3.46	0.55	5.40	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	34.76	13.42	2.44	4.88	1.83	4.68	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.40	12.55	1.83	3.42	2.05	2.05	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	35.63	11.46	2.24	3.49	1.49	1.62	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	33.01	12.24	3.28	3.06	0.87	3.28	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.69	18.62	2.66	3.55	2.36	1.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	44.83	17.17	2.54	4.29	1.59	3.18	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	40.89	15.42	4.02	3.35	1.12	2.01	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	43.15	19.96	2.22	4.44	1.61	1.81	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	48.18	20.19	0.68	3.56	0.85	2.04	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	34.32	15.34	1.51	4.08	1.68	2.93	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	45.47	20.81	1.77	5.51	2.50	1.04	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	47.13	19.13	0.85	4.44	2.39	1.54	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	43.71	15.71	2.10	3.21	1.22	1.66	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	40.60	16.89	1.66	3.08	1.75	1.58	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.53	15.52	2.25	3.47	2.25	2.65	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.50	17.74	2.06	5.16	2.48	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	43.81	16.37	1.73	3.34	2.08	0.92	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	46.86	17.84	1.00	3.67	2.67	1.50	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	38.58	17.85	2.20	1.98	1.32	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	47.35	18.82	1.48	5.41	3.07	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	43.77	17.02	2.27	3.08	0.97	1.62	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	37.84	16.36	2.25	4.81	1.28	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	44.44	15.73	1.33	4.26	2.18	0.76	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	38.44	18.19	0.79	3.01	1.90	0.79	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	40.14	16.12	1.52	3.04	1.52	2.43	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	44.43	17.46	1.67	2.82	1.99	0.73	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	37.76	14.71	2.20	4.39	1.32	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	35.63	11.78	1.68	2.52	1.68	1.12	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	45.83	10.93	1.11	2.04	1.39	0.65	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	45.99	12.03	1.34	2.41	0.80	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	39.17	9.18	1.53	1.84	1.84	0.77	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	42.75	10.36	1.30	1.94	2.20	0.52	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	47.17	9.76	1.08	2.98	1.63	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	38.35	11.06	1.11	2.95	1.66	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	45.40	12.28	0.66	3.73	3.95	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	39.67	8.93	0.00	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	40.37	9.23	1.06	2.64	0.79	0.53	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	34.10	10.09	1.01	2.02	1.01	0.40	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	45.49	9.66	1.27	2.03	0.25	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	46.58	21.90	5.77	0.60	1.79	1.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	31.12	16.18	4.16	2.62	1.23	2.00	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	44.19	23.32	2.86	3.68	2.05	1.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	31.92	17.21	7.20	4.69	0.94	3.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	30.80	21.76	5.93	4.24	4.24	4.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	17.99	11.99	11.07	2.77	1.38	3.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	51.97	14.85	14.85	0.00	2.47	2.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.91	20.11	6.19	3.87	3.09	4.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	49.74	16.04	3.21	3.21	4.81	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	15.65	6.96	1.74	5.22	5.22	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	41.01	15.95	5.53	4.56	3.25	2.93	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	32.94	19.35	2.47	4.94	0.82	2.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	13.33	0.00	6.66	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	49.78	14.54	5.03	3.64	1.12	2.24	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	35.63	13.40	4.25	2.61	1.63	2.61	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	37.75	10.90	5.03	2.52	0.84	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	45.80	12.09	3.50	2.86	1.91	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	39.74	13.93	3.74	3.06	0.68	1.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	58.47	25.06	6.26	4.18	0.00	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	55.55	21.19	6.87	4.58	1.72	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	44.40	10.66	5.33	3.26	0.89	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	71.15	13.55	5.08	0.00	1.69	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	53.43	21.12	5.38	2.49	2.07	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	50.86	15.65	5.06	3.91	1.61	1.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	36.88	10.54	0.00	0.00	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	62.66	15.38	3.08	3.46	1.92	2.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	52.81	11.73	2.61	1.63	0.33	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	67.55	14.05	2.68	2.01	2.01	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	48.54	12.71	6.55	2.70	1.16	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	31.15	7.53	2.74	0.68	1.71	1.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	42.24	9.94	4.97	2.48	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	38.69	7.08	4.72	3.77	0.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	34.40	9.05	2.41	0.60	0.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	38.66	11.70	1.53	2.54	1.02	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	57.83	15.95	5.58	1.99	2.79	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	46.38	14.80	3.95	1.48	0.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	38.95	12.98	7.08	1.18	1.18	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	46.68	7.00	5.25	4.08	0.00	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	34.23	5.27	2.19	0.44	0.00	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.89	5.09	5.93	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	48.95	11.34	2.39	1.19	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	55.80	21.84	1.46	2.91	0.97	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	76.47	6.85	4.57	4.57	2.28	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	38.26	9.56	1.25	1.25	0.42	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	75.34	11.24	2.25	2.25	2.25	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	31.08	4.44	0.32	1.90	0.63	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	35.51	4.60	2.51	2.51	1.67	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	77.63	13.11	3.60	3.02	0.81	0.70	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	72.75	10.63	2.19	3.04	1.35	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	60.06	11.60	2.50	2.28	1.82	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	73.89	13.55	4.70	2.19	2.40	0.66	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	73.07	11.61	2.79	2.79	1.07	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	62.65	9.26	2.58	1.29	1.08	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	78.96	13.82	3.36	4.36	2.24	0.50	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	66.73	11.15	3.60	2.92	1.54	0.69	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	64.72	15.38	1.60	2.24	2.56	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	59.88	20.71	1.68	0.56	2.24	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	49.34	9.95	0.00	0.43	2.60	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	29.08	7.93	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	73.37	11.29	0.71	0.35	1.76	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	90.81	12.35	0.00	1.45	0.73	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	47.91	6.29	0.70	0.70	1.22	0.00	0.00
Hepatocyte, donor1	11523-119I2	111.38	4.84	1.21	0.00	1.21	0.00	0.00
Hepatocyte, donor2	11603-120I1	100.19	8.62	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	93.87	9.20	0.00	0.00	0.61	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	68.53	24.80	16.32	0.65	0.65	3.26	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	38.80	7.52	2.62	0.87	0.35	0.70	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	25.79	7.13	0.69	2.06	1.37	0.55	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	3.18	9.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	6.68	6.68	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	26.30	5.54	5.54	1.38	0.00	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	15.02	12.51	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	83.08	11.87	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	35.88	0.00	0.00	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	9.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	30.86	3.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	38.35	8.34	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	7.26	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	5.29	2.65	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	49.89	3.33	4.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	10.48	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	36.53	8.82	2.52	1.26	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	41.76	7.73	3.09	0.00	0.00	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	34.24	8.40	0.00	0.65	0.65	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	45.08	6.44	1.61	1.61	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	47.79	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	46.45	4.89	4.07	0.81	0.00	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	34.42	7.98	2.52	0.42	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	0.00	14.37	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	31.34	8.04	3.21	0.00	0.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	47.09	7.39	3.69	0.00	0.92	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	50.04	6.61	2.36	0.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	44.44	4.53	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	43.04	6.46	2.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	60.98	5.08	1.27	0.00	0.00	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	44.64	3.83	5.10	0.00	0.64	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	40.10	3.65	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	46.41	5.00	2.86	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	9.95	6.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	46.92	7.72	1.54	0.62	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	35.12	7.02	3.51	1.76	1.76	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	47.15	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	41.72	6.95	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	51.87	0.00	6.48	6.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	36.62	4.36	0.87	0.87	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	11.25	2.25	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	48.78	6.97	6.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	37.34	0.00	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	4.16	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	28.50	11.40	2.85	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	48.78	3.68	1.84	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	45.38	3.03	6.05	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	80.71	0.00	6.21	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	35.95	5.29	2.11	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	13.06	1.96	0.33	0.33	0.65	0.00	0.00
Keratinocyte - epidermal, donor2	11349-117G8	24.60	2.93	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	21.58	8.42	3.31	2.46	1.04	0.66	0.09
Keratinocyte - oral, donor1	11251-116E9	33.26	10.10	1.02	1.25	1.59	0.57	0.00
Keratocytes, donor1	11527-119I6	60.86	12.03	4.47	2.75	2.75	1.03	0.00
Keratocytes, donor2	11607-120I5	59.76	14.06	0.00	2.34	3.52	2.34	0.00
Keratocytes, donor3	11688-122I5	37.35	14.62	0.00	1.38	1.19	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	259.35	15.39	13.19	2.20	0.00	4.40	0.00
Lens Epithelial Cells, donor1	11529-119I8	25.89	9.71	2.16	1.08	1.08	1.08	0.00
Lens Epithelial Cells, donor2	11609-120I7	53.63	15.34	1.38	3.92	1.38	1.73	0.00
Lens Epithelial Cells, donor3	11690-122I7	31.69	6.76	0.30	0.50	1.31	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	50.51	13.87	0.83	1.07	1.42	0.36	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	38.79	15.91	1.12	0.28	1.40	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	37.15	13.85	0.31	1.10	1.89	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	53.23	16.13	1.61	1.08	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	45.38	15.44	1.58	1.58	3.15	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	45.61	13.37	0.75	0.75	2.26	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	42.68	13.54	0.41	2.46	1.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	49.81	15.93	1.01	1.52	1.77	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	42.37	13.37	0.56	1.69	1.83	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	37.97	13.84	2.37	2.77	3.96	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	40.72	13.96	0.78	1.36	1.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	53.32	16.11	0.93	1.48	2.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	47.04	18.81	0.35	2.79	3.14	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	40.55	13.12	0.72	1.67	0.95	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	41.48	12.09	0.41	0.69	1.10	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	39.73	16.01	1.23	1.23	3.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	48.63	17.15	1.25	2.49	2.49	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	42.09	18.85	0.91	1.83	1.28	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	40.15	13.82	0.99	1.65	1.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	43.05	18.16	1.76	2.34	2.05	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	42.82	19.42	0.50	1.99	1.74	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	57.71	11.15	0.97	0.00	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	40.13	11.58	1.89	0.81	1.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	50.11	15.89	0.61	2.42	3.63	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	46.14	11.92	1.04	1.04	1.56	0.52	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	33.08	11.94	0.63	1.26	1.68	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	42.56	13.53	1.20	1.65	1.95	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	41.27	11.69	1.38	0.69	2.06	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	44.21	16.18	0.75	1.69	1.13	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	47.50	16.75	0.64	1.38	2.33	0.53	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	47.00	10.66	0.97	0.48	0.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	46.97	15.55	0.00	2.65	1.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	50.30	15.98	0.87	0.87	2.23	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	46.65	15.18	0.74	1.48	1.48	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	42.75	16.55	0.99	0.49	1.98	0.00	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	42.35	12.65	0.96	1.65	1.10	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	48.25	12.87	0.32	0.96	2.25	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	35.30	11.87	1.22	2.43	2.13	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.61	12.88	1.40	1.82	1.54	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	51.56	8.89	1.07	2.49	2.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	48.48	18.91	0.48	1.45	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	49.95	16.18	0.78	0.78	2.33	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	53.72	11.82	3.94	1.07	2.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	42.14	15.35	1.31	1.96	1.63	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	45.20	13.65	1.18	1.41	1.88	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	49.01	14.23	0.50	1.24	1.98	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	44.31	17.93	1.54	1.54	1.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	46.84	18.20	1.49	1.49	2.39	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	72.51	15.86	6.80	0.00	2.27	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	69.81	13.04	4.60	2.30	3.07	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	66.80	14.84	5.20	2.23	2.23	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	44.01	11.00	5.92	3.81	1.69	1.69	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	63.30	16.88	3.52	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	79.39	12.14	5.60	2.80	4.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	41.74	14.94	4.64	2.06	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	70.18	16.65	3.57	0.00	1.19	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	64.24	9.95	4.75	3.39	2.94	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	50.89	11.92	5.53	2.62	1.74	1.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	72.03	20.26	2.25	2.70	3.15	1.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	53.92	15.72	4.34	3.25	2.57	2.17	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	46.22	13.87	2.57	4.11	1.54	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	57.16	15.17	4.94	3.18	1.76	1.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	53.97	11.99	4.00	2.00	2.67	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	51.45	8.66	3.57	4.08	3.06	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	63.77	15.47	6.14	4.27	3.74	0.53	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	61.78	12.66	4.35	4.72	3.02	0.76	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	46.63	17.18	6.75	3.07	2.45	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	63.60	8.15	11.42	2.45	2.45	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	48.10	13.95	6.25	1.67	1.04	1.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	45.68	13.45	4.48	2.80	0.84	1.12	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	50.49	15.46	2.06	5.15	1.03	2.06	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	53.42	15.97	10.16	1.45	1.74	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	53.81	11.66	3.29	3.59	2.99	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	56.43	11.07	3.87	4.43	2.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	62.92	11.31	4.95	3.53	0.71	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	43.88	16.23	3.69	1.84	1.84	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	43.75	12.66	12.66	2.30	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	49.50	16.50	7.29	4.22	1.15	3.07	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	53.22	7.93	7.93	5.66	2.26	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	51.69	14.77	9.03	2.46	2.46	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	54.23	10.39	3.62	4.07	2.71	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	44.52	14.36	5.75	4.31	3.59	1.44	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	47.80	9.71	5.98	2.99	1.49	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	53.51	11.15	4.09	1.11	1.11	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	48.67	12.49	6.46	2.58	1.72	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	63.37	9.42	8.56	3.43	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	59.31	11.33	5.66	2.67	1.67	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	49.47	19.31	4.83	3.02	2.41	1.81	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	61.15	10.66	6.40	2.84	3.55	2.13	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	59.46	13.40	5.84	3.78	1.72	3.44	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	50.45	14.49	8.59	1.61	3.76	1.61	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	57.91	10.77	8.08	1.35	1.35	1.35	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	46.30	14.08	3.33	4.07	1.48	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	83.73	13.96	8.14	1.16	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	66.64	11.64	9.52	2.12	4.23	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	56.82	11.60	4.40	2.00	0.00	2.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	42.89	10.90	5.09	1.45	1.45	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	83.55	15.33	9.20	0.00	1.53	2.30	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	70.54	12.33	5.43	2.96	2.47	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	58.34	8.47	0.00	3.76	1.88	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	80.95	14.58	8.55	3.02	2.51	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	56.78	12.17	5.86	0.90	1.35	1.35	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	43.03	10.33	3.44	3.44	5.16	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	64.57	17.81	4.45	5.34	1.34	2.23	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	39.49	10.17	6.65	4.30	0.78	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	51.46	14.51	6.60	3.96	1.32	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	63.83	15.05	5.71	5.19	1.56	1.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	54.70	12.69	5.25	2.19	1.75	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	44.17	15.65	2.80	4.47	1.12	3.35	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	58.74	11.48	6.18	3.97	1.32	3.09	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	62.87	15.43	6.17	2.70	1.93	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	46.08	14.18	4.05	1.01	1.52	3.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	55.75	8.17	7.69	2.88	1.44	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	48.90	13.91	6.76	3.58	1.59	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	38.89	9.11	3.04	2.43	0.61	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	57.41	17.98	5.53	0.00	1.38	2.08	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	52.44	14.44	3.80	3.04	1.14	3.42	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	40.80	10.33	5.16	1.55	1.55	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	59.86	11.49	3.02	1.21	3.63	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	50.07	9.19	3.80	1.58	1.27	0.95	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	35.72	10.13	5.86	0.53	2.13	1.60	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	68.39	17.81	5.75	1.15	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	49.88	15.94	5.66	1.03	1.03	4.63	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	34.66	14.85	4.24	4.24	2.83	3.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	66.96	17.59	3.97	1.13	1.70	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	50.76	15.81	2.50	3.33	1.66	2.08	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	43.85	11.75	6.26	3.13	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	63.47	18.37	5.43	0.00	0.84	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	60.40	12.08	6.04	2.79	1.39	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	32.78	12.04	3.35	0.67	2.01	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	56.67	19.25	5.88	1.60	2.14	1.60	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	57.38	14.55	5.25	2.42	0.40	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	45.89	8.26	8.26	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	63.13	17.78	2.67	0.89	1.78	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	57.56	10.26	5.13	1.14	1.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	57.52	16.10	6.14	3.83	3.07	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	51.43	17.51	6.57	0.55	1.64	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	51.23	9.35	11.14	2.23	0.45	1.78	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	46.01	14.30	3.38	2.60	0.52	1.82	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	86.20	13.93	3.98	2.65	1.33	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	54.04	8.31	2.08	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	138.12	8.89	0.46	2.51	1.37	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	122.03	5.87	0.55	0.37	0.55	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	135.54	5.64	0.66	1.31	1.84	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	63.19	8.50	1.59	0.53	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	49.75	4.75	0.63	0.48	0.48	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	42.67	5.84	0.56	0.42	0.83	0.00	0.14
Mammary Epithelial Cell, donor1	11273-116H4	29.49	4.09	5.58	1.00	1.00	1.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	27.80	6.66	1.74	0.87	1.16	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	28.93	3.99	4.24	2.00	0.50	1.00	0.00
Mast cell - stimulated, donor1	11487-119E2	53.56	6.10	0.00	0.68	0.68	0.68	0.00
Mast cell, donor1	11563-120D6	70.94	9.95	1.62	0.97	0.87	0.11	0.11
Mast cell, donor2	11565-120D8	31.20	2.38	0.59	0.89	0.00	0.59	0.00
Mast cell, donor3	11566-120D9	31.29	0.45	0.23	0.23	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	45.21	2.30	0.18	0.35	0.18	0.18	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	61.77	5.32	0.33	0.67	0.67	0.11	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	30.35	1.75	0.00	0.58	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	110.59	11.70	1.95	1.49	0.69	0.23	0.11
Mast cell, expanded, donor8	11941-126A6	47.70	4.69	1.51	0.50	0.67	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	59.90	15.32	1.79	1.49	1.29	0.20	0.20
Melanocyte - dark, donor2	11582-120F7	57.80	11.07	1.38	1.04	1.38	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	29.48	4.71	1.38	1.59	1.16	0.43	0.00
Melanocyte - light, donor1	11274-116H5	35.03	5.88	0.94	1.65	1.18	0.24	0.00
Melanocyte - light, donor2	11351-117H1	41.63	2.73	2.05	1.36	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	25.15	6.07	0.87	0.87	0.00	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	27.28	5.00	0.73	2.19	0.73	0.21	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	32.27	6.99	2.69	3.50	2.69	0.54	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	28.12	6.43	0.27	2.95	1.34	0.27	0.00
Meningeal Cells, donor1	11493-119E8	36.23	12.78	2.61	1.74	2.98	0.74	0.00
Meningeal Cells, donor2	11573-120E7	47.54	18.49	0.44	1.32	2.64	0.44	0.00
Meningeal Cells, donor3	11654-122E7	23.96	10.84	1.47	5.71	2.69	1.47	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	75.57	15.68	5.70	4.85	2.57	3.99	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	41.36	6.24	0.20	0.91	0.81	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	69.65	15.77	5.26	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	73.26	14.39	1.31	1.31	5.23	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	55.97	10.76	2.15	1.44	1.44	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	56.75	8.89	0.64	0.85	1.06	0.21	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	54.79	5.53	1.01	3.52	1.01	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	62.41	12.09	2.42	3.30	2.42	3.52	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	49.68	15.34	2.19	2.19	3.65	5.11	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	60.77	12.28	3.07	4.50	1.84	2.05	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	68.70	11.91	1.52	0.97	1.80	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	80.29	8.55	0.37	0.00	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.97	6.05	0.26	1.71	1.05	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	59.35	10.98	0.59	0.89	1.48	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	51.38	9.34	0.00	4.67	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	55.07	11.53	2.56	3.20	1.92	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	62.38	12.41	1.06	0.71	1.77	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	41.28	5.94	0.63	1.88	1.56	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	56.60	14.51	5.08	0.73	1.45	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	50.12	6.36	0.00	0.80	0.27	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	87.58	7.01	0.50	0.50	3.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	43.36	3.76	0.22	0.22	0.36	0.22	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	144.48	9.45	1.35	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	150.72	6.65	0.49	0.25	0.99	0.49	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	117.49	5.89	0.29	0.88	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	79.51	6.91	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	123.05	5.27	0.62	0.93	0.93	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	95.63	6.02	0.83	0.62	1.04	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	60.22	0.00	2.32	2.32	2.32	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	137.64	5.76	1.00	1.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	108.46	3.72	0.93	0.47	0.47	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	97.33	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	124.98	4.67	0.41	1.63	1.42	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	101.37	5.54	0.00	1.98	1.58	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	103.54	3.54	0.00	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	140.96	4.94	0.00	0.38	0.76	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	68.43	1.32	1.32	0.00	0.00	2.63	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	121.60	4.67	0.00	0.64	0.64	1.06	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	72.75	0.92	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	79.28	3.28	1.19	1.49	0.89	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	60.36	3.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	101.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	93.34	6.52	0.25	0.25	1.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	84.37	3.57	0.00	0.95	1.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	58.61	0.55	0.55	0.00	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	99.70	2.76	0.92	0.46	0.46	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	94.86	4.21	0.00	0.42	1.26	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	71.14	2.45	0.41	0.61	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	108.99	3.00	0.43	1.29	0.43	0.64	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	84.47	3.78	0.00	0.89	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	79.07	1.10	0.44	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	79.09	6.08	0.00	0.00	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	64.62	3.31	0.00	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	80.18	4.35	0.00	0.54	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	81.46	3.53	1.18	0.29	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	51.25	3.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	92.75	3.84	1.44	0.48	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	74.44	3.20	0.40	1.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	28.80	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	111.13	6.01	0.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	55.04	0.00	2.04	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	83.64	2.63	0.44	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	73.94	3.31	0.00	0.00	0.00	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	52.51	4.48	1.28	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	82.06	3.72	0.25	0.50	0.50	0.25	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	64.02	3.48	0.70	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	70.72	2.21	0.00	0.00	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	87.18	5.81	0.34	1.03	0.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	73.52	4.38	0.88	0.00	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	45.81	2.84	0.71	0.00	0.36	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	91.18	4.21	0.56	0.56	1.96	0.56	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	93.10	3.33	0.42	0.42	1.66	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	49.53	2.33	0.58	1.17	1.17	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	58.82	3.92	0.60	0.00	0.60	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	93.08	2.92	0.42	0.00	0.42	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	67.42	3.69	0.92	0.92	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	88.78	7.97	0.57	1.14	0.57	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	74.76	3.87	0.28	0.97	0.69	0.69	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	79.82	4.15	0.78	0.26	0.78	0.78	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	82.79	6.43	0.43	0.86	1.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	47.64	5.08	0.64	3.81	0.00	1.91	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	58.45	4.00	0.53	0.27	0.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	135.30	11.08	1.20	0.60	1.50	0.60	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	79.38	5.09	0.71	0.28	0.14	0.71	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	88.55	7.64	0.00	1.27	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	103.27	8.40	0.66	1.77	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	60.29	6.07	0.38	0.38	0.76	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	92.62	5.68	0.28	1.70	1.42	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	117.00	11.06	0.74	1.23	1.72	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	72.99	2.61	0.65	1.30	1.96	1.30	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	91.74	5.29	0.88	0.59	1.47	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	149.35	10.09	0.58	0.86	0.86	1.15	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	99.74	4.12	0.82	1.24	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	115.84	7.15	0.30	1.19	0.89	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	199.64	7.53	0.00	3.77	7.53	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	204.96	10.69	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	157.71	4.93	0.33	0.66	1.64	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	153.59	8.42	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	94.49	3.16	0.40	0.59	0.20	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	101.51	6.52	0.00	0.00	1.86	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	144.20	9.01	0.38	1.88	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	135.83	5.06	1.07	1.07	1.07	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	147.26	7.01	0.23	1.13	0.90	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	125.24	8.84	1.47	2.21	0.74	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	140.71	6.60	1.10	0.00	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	113.56	4.67	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	245.31	8.55	1.07	1.60	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	100.46	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	153.51	9.09	1.01	0.00	3.03	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	171.19	5.48	0.42	0.84	1.69	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	414.03	12.26	0.00	0.00	4.09	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	337.61	19.71	1.27	2.54	3.18	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	402.49	28.34	0.81	4.86	3.24	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	232.61	9.06	3.02	1.51	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	148.46	5.71	5.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	309.93	6.52	9.79	6.52	3.26	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	152.08	4.75	0.00	0.00	0.00	0.00	4.75
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	48.04	15.08	0.43	3.02	2.37	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	51.74	14.11	1.57	4.70	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	20.02	2.67	0.00	0.67	2.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	27.13	2.09	0.42	0.83	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	53.62	4.56	0.38	4.37	1.71	0.38	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	87.77	9.58	4.79	3.19	1.60	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	10.20	2.04	1.36	0.00	0.00	0.68	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	60.64	3.68	1.84	9.19	7.35	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.51	1.67	0.84	1.26	0.42	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	28.59	2.56	1.39	0.70	0.46	1.86	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	24.32	3.51	0.00	0.81	0.81	0.27	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	39.10	4.84	0.84	1.68	0.21	0.63	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	0.00	11.13	0.00	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	40.70	3.97	1.49	0.00	0.99	0.00	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	24.63	2.71	0.27	2.98	0.27	0.00	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	20.63	3.85	0.45	1.59	1.13	0.23	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	24.82	3.27	0.49	0.82	0.33	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	44.29	6.38	0.18	1.28	0.18	0.73	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.34	3.71	0.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.61	1.80	0.00	1.20	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	38.72	5.58	0.00	4.92	2.63	0.00	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	17.40	0.98	0.33	1.14	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	32.81	3.70	0.35	0.18	0.53	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.77	1.41	0.00	0.00	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	19.31	2.30	0.00	0.92	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	28.92	2.25	0.32	1.29	0.96	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	34.14	7.24	1.03	5.17	2.07	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	70.80	12.64	0.00	12.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	28.52	3.12	0.45	0.22	0.67	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	13.97	2.12	0.85	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	21.60	1.42	0.24	0.71	0.71	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	36.49	3.00	0.43	1.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	9.03	0.00	18.06	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	31.99	4.33	0.00	1.33	0.33	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.64	3.16	0.45	0.45	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	14.68	0.79	1.19	0.79	0.79	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	21.36	0.93	0.00	0.93	0.93	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	40.11	1.51	0.00	0.38	1.14	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.83	2.93	0.65	0.98	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	22.23	3.49	0.87	0.87	0.87	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	32.11	3.62	0.45	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	5.29	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	27.26	1.33	0.66	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	37.20	3.97	0.00	0.99	0.99	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	19.52	0.77	0.38	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	33.27	2.42	0.30	3.02	1.21	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	35.14	1.99	0.44	1.11	1.11	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	28.46	0.00	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	34.75	1.22	0.61	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.55	0.94	0.00	0.31	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	19.98	2.12	0.30	0.61	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	23.73	3.16	0.00	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	54.41	4.53	0.00	9.07	5.67	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	75.87	15.17	0.00	15.17	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	43.48	5.71	0.75	1.86	1.37	0.62	0.12
Myoblast, donor2	11322-117D8	49.10	8.63	0.77	2.30	2.30	0.58	0.19
Myoblast, donor3	11398-118D3	51.96	9.08	0.67	0.84	1.18	0.84	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	40.57	10.51	9.34	2.19	0.58	1.46	0.00
Natural Killer Cells, donor1	11230-116C6	41.82	6.15	0.31	1.54	0.62	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	48.55	4.82	0.60	0.00	0.30	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	49.51	5.15	0.00	0.74	0.00	0.37	0.00
Neural stem cells, donor1	11275-116H6	35.21	18.87	1.09	9.44	4.36	0.73	0.00
Neural stem cells, donor2	11352-117H2	48.14	13.48	0.00	5.78	5.78	0.00	0.00
Neurons, donor1	11494-119E9	91.03	13.65	4.55	6.83	2.28	2.28	0.00
Neurons, donor2	11574-120E8	109.42	18.93	1.10	1.98	1.98	1.76	0.22
Neurons, donor3	11655-122E8	77.28	13.15	1.64	1.64	4.11	2.47	0.00
Neutrophils, donor1	11233-116C9	76.10	1.86	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	78.27	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	85.52	0.00	0.00	0.00	0.00	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	49.99	16.62	1.66	3.32	1.31	0.24	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	64.47	13.02	1.30	4.23	1.30	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	72.40	19.05	1.40	1.40	3.01	1.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	22.85	2.89	0.28	1.10	0.41	0.28	0.28
Olfactory epithelial cells, donor2	11934-125I8	31.41	4.92	1.30	2.03	1.16	0.58	0.00
Olfactory epithelial cells, donor3	11935-125I9	38.59	5.56	0.00	1.25	1.14	0.23	0.11
Olfactory epithelial cells, donor4	11936-126A1	32.92	6.82	0.68	1.85	0.88	0.49	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	47.54	7.22	1.81	0.60	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	51.26	8.93	0.43	2.13	1.06	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	76.59	9.14	2.29	2.29	1.14	0.00	1.14
Osteoblast - differentiated, donor3	11425-118G3	91.87	19.24	3.10	6.83	4.97	0.62	0.00
Osteoblast, donor1	11277-116H8	76.03	15.44	2.74	1.95	2.15	1.95	0.59
Osteoblast, donor2	11354-117H4	44.95	11.94	0.70	1.40	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	90.46	14.75	3.55	5.51	3.02	0.18	0.53
Pancreatic stromal cells, donor1	11249-116E7	54.33	8.26	1.52	3.62	1.60	0.93	0.08
Pericytes, donor1	11491-119E6	69.88	22.25	1.67	2.56	3.56	0.45	0.00
Pericytes, donor2	11571-120E5	82.62	35.54	1.13	3.62	6.79	0.91	0.00
Pericytes, donor3	11652-122E5	55.34	10.17	0.41	2.64	0.81	0.20	0.20
Perineurial Cells, donor1	11499-119F5	35.15	11.64	1.47	3.62	1.36	1.13	0.11
Perineurial Cells, donor2	11579-120F4	57.51	9.75	0.55	1.10	0.64	0.28	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	66.62	2.55	0.32	1.27	0.64	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	54.85	2.69	0.49	0.24	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.73	3.24	0.26	0.39	0.26	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	67.21	6.70	2.63	0.96	0.96	1.67	0.00
Placental Epithelial Cells, donor2	11355-117H5	83.17	9.98	3.33	1.11	2.22	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	56.15	11.19	3.53	3.14	1.57	0.20	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	91.45	7.59	0.32	0.63	0.63	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	53.09	5.82	0.19	1.31	1.13	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	27.93	3.79	0.00	0.39	0.39	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	70.92	9.46	0.45	1.80	0.90	0.23	0.00
Preadipocyte - omental, donor1	11468-119C1	50.08	5.43	0.43	1.92	0.85	0.00	0.00
Preadipocyte - omental, donor2	11329-117E6	62.42	11.35	0.00	1.31	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	57.59	7.88	0.14	1.15	1.15	0.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	72.84	15.75	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	51.90	5.22	1.54	1.54	0.31	1.23	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	59.14	10.09	1.59	2.12	0.89	0.89	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	69.14	10.90	1.02	2.72	2.21	0.85	0.00
Preadipocyte - visceral, donor1	11280-116I2	48.25	7.54	1.68	3.07	2.14	1.77	0.09
Preadipocyte - visceral, donor2	11357-117H7	45.56	9.20	1.84	1.84	0.92	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	64.47	13.17	2.19	1.36	2.72	2.09	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	30.17	7.54	1.21	0.75	0.30	0.45	0.00
Prostate Epithelial Cells, donor2	11331-117E8	22.07	2.44	0.68	0.14	0.14	0.00	0.00
Prostate Epithelial Cells, donor3	11404-118D9	19.84	4.84	0.92	1.10	0.67	0.00	0.00
Prostate Stromal Cells, donor1	11254-116F3	52.05	7.75	0.91	1.59	1.71	0.46	0.11
Prostate Stromal Cells, donor2	11332-117E9	53.25	12.01	2.15	3.41	2.51	1.26	0.18
Prostate Stromal Cells, donor3	11405-118E1	62.77	10.11	0.73	2.61	1.56	0.21	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	52.56	10.22	1.82	1.09	1.82	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	25.30	6.24	2.08	1.94	0.76	1.04	0.00
Renal Epithelial Cells, donor1	11517-119H5	71.52	6.59	3.55	2.03	1.52	2.54	0.00
Renal Epithelial Cells, donor2	11597-120H4	60.46	13.52	4.98	1.42	2.13	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	30.49	7.09	1.27	1.38	1.27	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	76.94	14.98	3.40	1.36	2.04	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	54.98	9.30	1.08	0.40	1.35	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	38.41	9.32	3.33	1.11	2.44	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	42.59	8.65	1.33	0.00	3.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	71.97	15.19	2.20	1.76	0.88	1.10	0.00
Renal Mesangial Cells, donor2	11598-120H5	69.60	18.81	1.88	1.25	3.76	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	61.59	15.81	1.11	1.94	1.94	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	46.71	9.66	2.68	1.34	2.15	1.61	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	42.17	7.59	2.53	0.42	1.27	1.69	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	52.07	17.16	2.70	2.51	2.12	1.54	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	49.52	8.56	3.63	1.81	1.30	5.19	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	46.33	9.66	1.42	1.42	0.57	1.42	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	39.11	9.26	4.12	2.06	1.03	2.06	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.84	11.54	0.00	3.01	2.01	1.00	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	86.33	8.42	0.53	0.67	0.94	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	10.72	0.89	1.79	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	19.81	17.61	3.85	0.55	1.65	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	27.84	8.12	2.32	3.48	1.74	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	66.31	15.60	2.34	0.26	0.65	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	52.14	15.00	1.99	0.79	1.59	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	51.64	13.05	1.78	1.34	1.67	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	58.67	18.98	2.36	1.24	2.11	0.50	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	55.83	17.25	1.86	1.05	2.10	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	51.08	15.72	3.70	1.16	1.62	0.46	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	59.14	12.73	2.46	0.82	1.23	0.55	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	50.83	15.58	1.36	0.45	2.12	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	60.92	15.77	3.05	1.43	1.61	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	59.82	15.78	2.01	1.00	2.30	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	52.26	16.63	1.82	1.07	2.04	0.43	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	65.05	13.72	1.77	1.55	2.21	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	51.24	13.57	2.10	0.57	0.96	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	51.15	11.55	2.05	1.40	1.21	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	37.39	15.60	0.75	1.32	0.75	0.56	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	67.28	15.79	3.05	0.40	1.33	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	56.07	11.68	1.85	1.07	1.07	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	54.81	15.09	1.34	1.53	1.72	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	61.51	17.30	2.24	0.32	1.28	0.43	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	43.45	13.17	1.40	1.40	0.56	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	53.32	14.36	1.88	2.22	1.88	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	61.08	14.22	1.46	0.18	1.09	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	49.67	13.00	2.21	1.47	1.84	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	61.79	17.86	2.28	2.42	2.69	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	73.36	15.33	1.18	0.94	2.36	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	56.75	12.10	2.38	1.39	1.98	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	56.12	18.71	2.57	1.87	3.74	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	72.78	15.76	2.70	0.41	2.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	49.77	18.36	2.65	2.21	1.99	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	47.42	16.29	1.25	1.25	1.88	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	67.83	16.69	1.88	0.40	1.62	0.67	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	55.52	13.28	1.36	1.70	2.21	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	54.56	12.53	2.70	1.74	2.51	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	66.37	13.76	1.03	1.03	2.92	0.52	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	55.42	14.81	2.61	1.37	2.61	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	48.10	13.63	1.15	1.31	1.81	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	56.75	14.49	1.70	0.85	1.19	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	62.44	13.91	1.78	0.89	0.89	0.89	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	50.91	12.26	1.87	0.80	1.07	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.03	18.80	2.77	0.41	1.24	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	60.24	20.24	1.19	0.71	1.90	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	47.56	12.09	2.22	0.60	1.61	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	59.71	18.46	1.70	0.38	1.51	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	35.98	13.97	1.75	3.14	1.75	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	45.63	13.30	3.02	1.81	1.51	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	68.78	16.28	2.94	0.86	1.59	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	34.93	11.21	3.49	2.33	1.60	0.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	59.02	20.08	4.87	0.00	1.22	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	67.21	16.88	2.41	0.60	1.21	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	37.55	10.86	3.17	1.58	0.90	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	36.54	12.58	2.40	2.10	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	44.87	10.27	3.31	0.71	0.94	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	42.05	16.65	3.84	2.77	1.28	1.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	47.48	8.41	3.61	1.20	0.00	0.60	0.00
Schwann Cells, donor1	11498-119F4	84.82	25.95	4.89	2.07	2.44	2.26	0.00
Schwann Cells, donor2	11578-120F3	37.43	0.00	0.00	3.40	3.40	3.40	0.00
Schwann Cells, donor3	11659-122F3	47.98	9.86	0.88	3.72	2.41	0.22	0.00
Sebocyte, donor1	11220-116B5	24.10	4.38	1.10	1.10	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	15.17	5.06	1.38	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	31.74	3.50	0.82	1.44	1.65	0.00	0.00
Sertoli Cells, donor1	11255-116F4	56.32	6.63	0.00	1.66	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	36.72	5.65	0.00	0.00	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	53.40	18.04	1.94	4.13	1.58	0.79	0.00
Skeletal Muscle Cells, donor2	11358-117H8	49.88	15.18	0.72	4.34	0.72	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	75.24	9.20	2.51	1.67	1.67	5.02	0.00
Skeletal Muscle Cells, donor4	11451-119A2	52.78	11.78	1.41	1.89	1.89	1.73	0.00
Skeletal Muscle Cells, donor5	11455-119A6	50.69	9.51	1.49	0.74	1.64	2.08	0.00
Skeletal Muscle Cells, donor6	11459-119B1	51.87	12.62	2.46	1.54	1.69	2.15	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	60.73	14.87	2.65	2.77	2.14	1.39	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	51.23	13.13	2.00	2.57	2.28	1.28	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	50.10	12.90	0.79	2.38	1.09	1.29	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	45.75	11.80	0.76	2.78	1.69	0.42	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	58.62	13.03	5.79	5.07	0.00	2.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	107.46	20.23	1.79	3.03	2.34	1.24	0.00
Skin - palm, donor1	10286-104F7	64.47	2.69	10.74	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	21.34	2.74	0.58	0.43	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	15.54	2.45	0.00	0.82	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	27.13	4.93	1.30	0.39	1.17	0.00	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	24.60	4.59	0.56	0.97	0.42	0.00	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	24.90	5.20	0.70	0.28	0.70	0.14	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	21.36	4.23	2.11	0.42	0.63	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	29.08	4.12	1.05	0.45	0.37	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	89.80	9.57	0.00	1.23	3.09	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.79	2.45	0.00	0.44	0.22	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	79.36	11.17	1.76	1.18	1.18	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	40.88	4.86	0.44	0.88	1.10	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	51.98	8.66	1.18	2.76	2.76	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	95.03	6.95	3.86	1.55	0.77	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	53.04	16.01	0.00	0.00	3.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	67.74	8.12	0.27	1.06	1.60	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	59.40	10.64	1.11	3.99	1.99	0.66	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	54.80	8.58	1.54	1.41	1.41	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	31.91	12.70	1.95	4.56	2.93	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	52.86	8.27	0.59	0.59	0.59	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	42.57	6.98	0.28	1.28	1.28	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	71.90	8.46	1.63	2.93	1.79	1.14	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	53.88	10.35	0.00	3.04	1.52	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	81.07	11.11	1.26	1.52	0.76	0.25	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	49.11	7.15	0.95	0.95	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	61.79	7.08	0.29	1.18	1.33	0.44	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	50.37	9.69	0.86	1.29	1.72	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	59.20	10.29	1.26	1.15	1.57	0.42	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	51.82	5.57	1.24	0.77	0.46	0.46	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	61.44	14.01	4.31	2.16	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	61.27	8.07	2.39	0.90	0.90	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	75.79	8.53	1.02	1.71	2.05	1.02	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	38.87	8.40	1.18	1.65	1.10	0.08	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	26.17	3.62	0.40	1.91	1.01	0.50	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	54.84	10.92	0.00	2.28	1.37	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	71.25	15.10	3.02	1.21	1.21	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	44.24	5.56	1.59	1.32	1.06	0.53	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	68.71	9.45	1.20	0.80	1.46	0.93	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	54.85	8.51	0.25	1.00	1.50	0.00	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	61.64	11.16	0.51	4.82	1.52	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	56.69	8.14	1.96	1.96	1.06	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	61.51	10.50	1.50	2.25	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	21.97	15.51	1.29	0.00	1.29	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	49.76	8.84	0.93	0.00	0.47	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	55.54	12.12	0.50	2.02	1.51	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	42.62	7.83	0.63	0.31	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	59.29	7.08	0.59	1.77	1.47	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	58.81	9.91	2.75	2.67	1.83	2.08	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	58.39	13.55	1.40	3.74	0.93	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	51.81	5.90	0.86	0.72	0.86	0.58	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	72.66	10.96	2.04	2.04	1.78	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	73.71	10.53	1.69	1.69	2.82	0.94	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	64.56	11.18	0.56	2.10	0.84	0.42	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	59.57	9.80	1.01	1.17	0.92	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	57.62	10.00	0.00	0.48	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	63.12	6.85	0.49	0.73	0.24	0.24	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	62.97	10.16	1.10	1.99	1.10	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	86.60	12.87	3.80	4.10	1.17	4.97	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	52.09	8.36	0.58	3.69	1.36	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	41.78	3.97	0.79	3.44	3.17	0.00	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	41.66	8.55	0.74	5.95	2.23	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	63.24	7.19	0.72	1.80	5.03	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	66.72	6.25	0.28	1.42	2.27	0.28	0.85
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	56.72	12.60	0.39	1.58	1.97	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	42.92	8.13	1.27	6.09	2.79	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	43.13	9.98	1.60	4.39	2.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	43.05	9.61	1.25	4.60	1.67	1.25	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	77.92	17.88	1.38	2.75	1.83	0.00	0.00
Synoviocyte, donor1	11291-117A4	15.82	3.03	0.34	2.19	1.01	1.18	0.34
Synoviocyte, donor2	11368-117I9	57.66	9.05	0.67	3.35	2.01	0.50	1.84
Synoviocyte, donor3	11440-118H9	60.54	6.48	1.12	1.34	1.12	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	71.82	16.08	2.86	3.57	3.22	3.22	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	41.62	3.96	3.96	3.96	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	52.56	14.12	3.47	3.01	0.93	3.70	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	18.85	4.87	2.80	1.43	0.14	0.72	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	35.18	7.34	2.71	1.16	0.39	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	21.76	4.01	2.29	0.57	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	88.09	8.37	0.37	1.48	0.86	0.00	0.00
Urethra, donor2	10319-105A4	59.35	3.60	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	33.47	5.05	1.06	0.27	0.00	0.27	0.00
Urothelial Cells, donor2	11600-120H7	28.04	6.41	2.00	0.80	1.60	0.00	0.00
Urothelial Cells, donor3	11681-122H7	30.71	3.44	1.38	0.46	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	22.51	4.24	1.11	0.22	0.45	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	144.14	8.90	2.67	0.00	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	151.54	18.58	0.00	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	97.20	9.58	0.68	0.68	1.37	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	81.95	3.79	1.03	0.34	0.69	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	80.76	7.55	0.00	1.74	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	129.11	6.25	1.04	0.00	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	140.42	7.34	0.00	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	76.68	6.39	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	21.83	6.66	3.33	4.07	2.47	0.74	0.00
Wilms' tumor cell line:HFWT	10597-108E3	15.84	4.40	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	44.41	10.06	3.91	0.56	1.40	0.00	0.28
achilles tendon, donor2	10292-104G4	31.00	6.20	4.13	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	60.68	17.85	3.06	1.78	2.04	4.59	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	68.96	15.79	5.34	2.79	0.93	0.70	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	45.47	8.78	4.63	1.66	0.47	0.59	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	66.12	17.42	3.81	2.45	0.54	1.09	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	10.40	2.53	0.00	0.28	0.84	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	106.59	8.46	2.33	2.33	1.27	0.63	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	18.78	4.36	0.27	0.82	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	39.22	7.49	0.44	0.44	2.20	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	71.05	8.98	1.63	2.45	1.63	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	80.38	12.81	1.55	3.88	1.94	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	41.95	8.46	0.92	1.10	0.92	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	15.60	7.80	3.90	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	42.29	13.71	3.49	1.16	1.63	1.16	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	86.21	12.95	1.55	2.85	2.59	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	99.36	9.64	5.26	1.75	1.46	1.17	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	54.84	3.72	6.51	0.46	0.46	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	61.28	9.87	2.06	1.65	0.82	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	37.14	2.15	4.60	0.31	0.31	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	60.59	10.67	2.13	2.13	1.28	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	74.00	9.40	1.52	1.82	2.12	0.91	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	71.73	12.76	2.65	2.41	1.44	0.48	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	61.25	8.91	2.45	4.90	1.34	1.11	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	55.37	10.67	3.34	0.67	1.33	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	65.04	16.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	51.60	13.94	1.13	2.64	1.88	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	28.78	5.23	1.31	0.44	0.44	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	35.61	11.25	1.87	0.00	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	62.64	3.77	5.18	1.88	1.18	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	48.71	6.20	0.47	1.09	0.16	0.00	0.00
adipose, donor1	10184-103D4	53.36	17.01	4.69	15.25	5.28	6.45	0.00
adipose, donor2	10185-103D5	13.79	6.08	2.43	6.08	0.81	0.81	0.00
adipose, donor3	10186-103D6	30.22	12.80	3.54	5.72	1.09	2.72	0.00
adipose, donor4	10187-103D7	25.14	14.73	6.93	1.73	0.00	4.33	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	65.97	15.47	9.31	2.21	1.58	0.47	0.00
adrenal gland, adult, pool1	10081-102A9	61.84	3.64	0.00	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	68.17	6.40	7.47	1.73	0.40	1.60	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	57.88	6.07	5.00	4.29	0.71	3.57	0.00
amniotic membrane cells, donor1	12235-129G3	73.26	5.10	1.39	1.39	1.39	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	105.83	15.55	7.10	3.38	0.68	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	101.64	7.07	0.00	1.47	0.88	0.00	0.00
amygdala - adult, donor10196	10167-103B5	73.52	8.30	0.00	0.00	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	101.59	5.27	0.00	0.41	0.61	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	56.81	5.81	0.00	0.65	0.32	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	28.65	8.15	1.40	1.27	0.13	0.64	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	59.35	12.13	3.53	2.87	1.99	0.88	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	29.06	3.34	4.34	0.33	1.00	0.67	0.00
aorta, adult, pool1	10052-101G7	42.76	5.10	0.78	2.16	0.59	0.00	0.00
appendix, adult	10189-103D9	86.94	7.37	0.39	0.78	0.39	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	68.79	15.82	3.78	1.38	2.06	0.34	0.00
artery, adult	10190-103E1	93.75	6.79	0.00	2.72	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	45.34	23.47	2.17	1.59	1.30	1.88	0.00
b cell line:RPMI1788	10427-106D4	22.60	6.69	2.83	0.74	1.19	1.64	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	54.66	8.88	1.11	3.61	1.39	0.55	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	38.60	4.07	3.67	1.29	0.79	0.60	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	16.40	2.85	1.34	0.84	0.17	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	78.29	15.10	3.91	2.80	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	54.97	5.76	1.09	1.74	0.43	0.11	0.11
blood, adult, pool1	10053-101G8	99.66	8.86	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	131.88	19.70	6.85	5.99	0.86	0.86	0.00
bone marrow, adult	10192-103E3	61.41	13.50	0.00	0.67	2.02	0.00	0.00
brain, adult, donor1	10084-102B3	105.58	7.18	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	92.98	7.91	0.00	1.00	1.00	0.11	0.00
brain, fetal, pool1	10085-102B4	82.81	8.01	0.00	2.67	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	71.36	11.56	3.30	7.60	1.98	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	24.22	7.74	1.12	3.74	1.25	0.37	0.00
breast, adult, donor1	10080-102A8	32.20	3.16	0.00	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	29.09	9.78	4.45	2.54	2.03	0.38	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	30.30	7.73	2.47	0.93	0.31	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	35.68	9.90	5.30	5.76	1.38	1.38	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	29.78	13.07	4.60	8.96	3.63	1.21	0.00
carcinoid cell line:NCI-H1770	10703-109H1	32.91	4.23	6.11	0.00	0.47	0.94	0.00
carcinoid cell line:NCI-H727	10735-110B6	59.50	8.53	3.94	0.77	0.77	0.77	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	42.46	23.13	3.17	6.65	5.07	3.17	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	54.03	15.17	2.40	5.32	2.40	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	75.99	6.91	0.00	1.15	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	91.19	5.86	0.00	0.67	0.33	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	107.74	6.11	0.00	2.29	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	44.31	6.23	0.00	1.46	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	61.18	5.83	0.00	0.00	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	57.01	2.99	0.00	1.07	0.21	0.00	0.00
cerebellum, adult, pool1	10083-102B2	49.67	2.76	0.34	0.34	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	38.19	15.78	0.00	4.15	2.49	0.00	0.00
cerebral meninges, adult	10188-103D8	111.45	13.36	0.00	3.78	2.52	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	70.16	8.77	0.00	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	55.36	25.02	7.05	8.48	2.88	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	43.09	11.77	12.59	1.99	0.66	1.66	0.00
cervix, adult, pool1	10013-101C4	61.52	6.40	0.63	1.15	0.73	0.10	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	34.83	5.43	0.28	0.70	0.70	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	44.41	7.84	2.61	3.92	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	24.48	17.40	2.98	1.99	0.37	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	23.04	23.90	3.70	1.85	1.23	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	21.58	14.23	3.79	0.71	0.95	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	53.00	7.98	3.13	0.57	0.28	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	76.96	13.12	1.69	1.39	1.39	0.50	0.10
chorionic membrane cells, donor3	12240-129G8	64.84	11.54	1.10	1.10	0.55	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	87.85	18.18	10.10	5.05	5.05	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	42.45	13.06	0.58	0.77	1.15	0.19	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	47.52	8.03	0.42	0.84	1.27	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	34.92	5.39	3.60	0.77	0.77	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	41.12	5.32	2.90	0.24	0.48	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	28.51	6.31	1.83	0.61	0.41	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	54.47	6.77	2.65	0.00	0.88	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	32.06	8.86	0.52	0.52	1.30	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	30.17	11.66	8.23	1.37	1.60	1.14	0.00
clear cell carcinoma cell line:TEN	10636-108I6	40.08	5.90	7.29	2.08	0.87	1.04	0.17
colon carcinoma cell line:CACO-2	10513-107D9	44.66	11.35	4.94	1.65	0.55	1.10	0.00
colon carcinoma cell line:COLO-320	10420-106C6	69.55	9.50	4.56	1.14	0.38	0.38	0.00
colon, adult, donor1	10082-102B1	96.39	7.14	2.38	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	154.75	10.58	1.76	1.88	1.29	1.06	0.12
colon, fetal, donor1	10070-101I7	79.10	4.33	0.62	0.00	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	41.25	0.00	22.92	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.75	5.95	1.70	1.27	0.42	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	25.36	6.49	1.96	1.66	0.45	1.66	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	24.82	6.35	3.10	1.41	1.13	2.96	0.00
corpus callosum, adult, pool1	10042-101F6	107.36	9.07	0.33	0.77	1.11	0.11	0.22
cruciate ligament, donor2	10295-104G7	59.97	4.05	0.81	3.24	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	45.75	5.62	1.61	0.00	2.41	0.00	0.00
diencephalon, adult	10193-103E4	92.40	7.68	0.48	2.40	0.72	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	56.48	15.15	7.58	4.59	1.38	0.69	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	40.00	17.18	9.49	3.59	1.54	1.54	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	13.24	2.89	0.00	1.44	0.72	0.48	0.00
ductus deferens, adult	10196-103E7	57.81	7.48	0.50	1.50	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	59.05	10.08	1.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	87.54	10.30	0.74	0.74	0.74	0.00	0.00
dura mater, adult, donor1	10041-101F5	61.78	7.43	0.91	2.23	0.91	0.50	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	19.76	4.89	0.67	1.78	1.78	5.11	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	45.28	16.05	1.43	2.15	1.29	1.15	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	38.23	13.57	1.85	1.23	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	25.73	9.08	2.42	0.61	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	39.83	10.50	2.47	0.31	0.93	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	56.48	13.13	1.31	0.00	1.31	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	18.10	9.39	3.02	3.35	1.01	1.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	61.62	12.51	3.62	1.45	1.27	0.91	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	30.39	13.51	3.06	1.29	2.41	0.32	0.00
epidermoid carcinoma cell line:A431	10426-106D3	22.90	5.78	2.89	1.67	0.89	0.67	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	35.31	7.70	4.51	1.87	1.32	0.88	0.11
epididymis, adult	10197-103E8	65.31	8.16	1.47	1.88	1.67	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	49.32	7.81	2.66	3.37	0.71	0.71	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	16.91	3.15	0.39	1.97	1.57	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	65.39	15.07	5.77	3.67	2.10	1.44	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	50.49	14.66	8.96	4.33	2.46	1.48	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	74.61	17.59	7.51	5.60	1.34	1.12	0.00
esophagus, adult, pool1	10015-101C6	77.51	7.96	1.17	0.96	1.06	0.32	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	18.03	8.39	1.13	4.88	1.63	0.25	0.00
eye - muscle inferior rectus, donor1	10272-104E2	65.19	7.24	0.00	4.83	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	58.92	2.10	0.00	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	65.48	5.95	2.98	4.46	1.49	0.00	0.00
eye - muscle superior, donor2	10297-104G9	64.20	10.32	0.00	2.29	0.00	2.29	0.00
eye - vitreous humor, donor1	10268-104D7	55.38	2.91	0.00	2.91	2.91	0.00	0.00
eye, fetal, donor1	10054-101G9	64.58	11.44	1.27	1.53	1.53	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	22.95	8.72	2.31	1.54	1.03	1.41	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	71.49	5.25	0.09	1.13	1.41	0.09	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	38.43	14.71	4.80	3.00	0.60	1.50	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	31.00	8.14	0.55	1.55	0.82	0.18	0.00
gall bladder, adult	10198-103E9	91.50	12.55	0.24	2.66	0.97	0.97	0.00
gamma delta positive T cells, donor1	11937-126A2	111.13	10.20	0.00	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	104.58	7.84	0.37	1.49	1.12	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	44.78	13.52	3.17	2.53	2.32	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	35.40	9.48	2.13	2.32	1.35	0.77	0.00
gastric cancer cell line:AZ521	10549-107H9	68.37	14.92	6.23	1.31	0.98	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	24.71	19.22	5.49	0.92	1.83	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	46.38	17.82	1.37	1.14	1.14	0.00	0.00
giant cell carcinoma cell line:LU65	10487-107B1	12.05	0.80	0.00	0.11	0.11	0.11	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	20.85	6.58	0.70	2.38	0.56	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	44.40	4.24	4.24	1.50	0.25	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	39.37	7.81	2.64	1.69	0.63	1.58	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	43.40	4.77	3.23	0.84	1.26	0.98	0.00
glioblastoma cell line:T98G	10485-107A8	29.47	4.53	2.98	2.10	0.44	0.66	0.00
glioma cell line:GI-1	10413-106B8	31.34	4.39	1.76	1.17	0.00	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	99.13	3.64	0.00	2.19	0.73	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	109.11	7.32	0.73	2.20	1.22	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	121.86	10.95	0.00	2.74	2.74	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	67.15	8.53	0.53	0.53	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	127.25	7.34	22.02	2.45	0.00	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	174.85	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	360.63	15.68	20.91	0.00	5.23	10.45	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.68	5.44	1.92	1.60	1.60	1.92	0.00
hIPS +CCl2, biol_rep1	14383-156B9	43.62	12.40	4.59	1.84	0.92	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	37.95	11.89	3.20	1.83	1.37	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	42.51	12.88	5.15	2.58	0.00	2.58	0.00
hIPS, biol_rep1	14380-156B6	15.81	14.37	4.31	4.31	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	40.47	10.97	2.74	0.69	2.74	1.37	0.00
hIPS, biol_rep3	14382-156B8	110.35	7.72	2.21	1.10	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	30.75	8.91	2.59	0.00	1.15	1.15	0.00
heart - mitral valve, adult	10205-103F7	39.76	5.08	0.60	1.49	0.90	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	41.31	5.75	1.05	2.35	1.05	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	49.13	3.33	0.00	0.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	57.34	11.84	3.47	1.84	1.43	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	61.75	2.98	0.85	0.85	0.43	0.43	0.00
heart, adult, pool1	10016-101C7	51.97	4.60	0.46	0.23	0.23	0.00	0.00
heart, fetal, pool1	10046-101G1	54.63	8.93	0.00	0.72	0.21	0.31	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.32	8.33	0.31	1.23	1.54	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	42.81	9.51	5.95	3.57	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	39.56	7.85	1.77	0.99	1.44	0.33	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	43.09	9.71	2.31	0.85	1.34	0.12	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	44.26	8.99	1.31	1.31	1.11	0.71	0.00
hepatoma cell line:Li-7	10484-107A7	23.47	6.34	1.00	0.67	0.44	0.56	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	33.17	12.56	7.94	3.42	2.61	2.31	0.00
hippocampus - adult, donor10196	10169-103B7	76.65	5.68	0.00	0.00	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	107.56	5.10	0.20	1.22	0.82	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	86.15	6.47	0.00	0.00	1.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	49.70	4.58	0.00	0.35	1.41	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	53.71	39.67	8.54	7.32	4.88	3.05	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	31.61	23.37	4.12	4.32	1.37	3.14	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	41.13	31.74	5.33	3.30	1.78	4.57	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	43.42	16.92	6.20	2.82	1.13	6.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	41.57	16.01	6.46	3.61	2.32	3.36	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	48.59	23.16	5.69	4.56	3.04	4.93	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	47.59	15.77	3.21	13.14	3.80	2.34	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	37.27	9.91	3.66	6.89	3.02	3.88	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	42.12	12.93	2.50	8.34	3.75	2.50	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	82.17	20.13	4.74	7.34	3.32	4.74	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	61.72	25.88	3.86	7.71	2.57	2.73	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	86.86	21.55	4.71	10.10	2.02	3.37	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	28.79	18.62	4.54	3.13	2.66	4.69	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	28.99	27.02	3.93	0.49	0.49	2.95	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	43.64	22.69	5.24	7.85	3.49	3.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	37.80	11.65	3.25	5.15	1.15	3.05	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	36.63	13.52	3.92	5.23	0.87	3.92	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	48.48	14.99	4.00	9.00	3.50	3.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	19.22	9.61	4.14	5.84	0.94	0.57	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	20.46	12.73	2.27	5.00	4.09	1.36	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	22.87	13.16	2.19	10.02	0.31	1.88	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	27.76	15.35	2.61	5.88	2.61	2.45	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	31.35	15.39	2.90	6.10	2.03	2.03	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	24.51	17.34	2.09	9.27	2.69	1.79	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	29.00	23.46	5.73	4.80	3.14	3.88	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	29.95	23.68	2.85	2.28	1.14	3.99	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	53.08	33.48	5.72	7.35	4.49	5.31	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	32.04	18.31	4.58	4.22	1.41	3.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	26.29	13.94	5.38	3.80	2.22	1.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	37.83	18.46	2.12	5.14	2.12	3.63	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	28.44	10.86	6.21	8.27	3.62	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	35.20	17.27	3.98	3.98	1.99	3.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	40.28	17.70	3.33	9.49	2.82	2.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	49.60	20.45	2.56	5.62	2.56	2.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	41.65	17.42	2.27	5.30	2.27	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	45.37	17.14	1.01	7.39	2.35	4.37	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	31.88	21.01	7.73	3.14	1.21	4.59	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	37.88	29.41	4.01	3.57	2.67	5.79	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	37.07	25.85	6.83	5.37	2.93	6.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	30.56	13.45	3.97	2.75	2.14	2.75	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	71.57	22.77	9.76	32.53	13.01	16.27	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	39.71	18.53	4.30	7.94	3.64	3.97	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	44.33	13.14	3.28	8.21	1.09	4.38	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	36.91	16.65	2.53	9.05	1.09	2.90	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	33.10	14.23	5.34	8.54	1.42	2.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	39.38	14.32	2.39	3.58	4.77	4.77	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	44.55	18.69	4.47	6.36	2.84	3.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	43.37	16.43	2.69	8.62	2.69	3.77	0.00
immature langerhans cells, donor1	11904-125F5	89.59	5.33	1.70	1.21	0.73	0.24	0.00
immature langerhans cells, donor2	11905-125F6	91.10	7.13	0.79	0.79	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	83.18	7.29	0.09	0.57	1.04	0.28	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	58.53	13.33	6.50	5.53	2.28	0.65	0.00
kidney, adult, pool1	10017-101C8	102.63	8.11	0.20	1.00	0.90	0.10	0.10
kidney, fetal, pool1	10045-101F9	62.46	6.30	0.50	1.06	0.35	0.21	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	40.19	12.36	0.43	0.85	0.43	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	43.13	7.05	0.97	0.83	0.28	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	30.09	7.52	6.06	0.92	0.73	1.83	0.00
left atrium, adult, donor1	10079-102A7	29.42	3.81	1.63	0.54	1.09	0.00	0.00
left ventricle, adult, donor1	10078-102A6	39.44	4.05	0.00	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	30.10	5.20	3.01	0.82	0.82	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	52.81	10.42	2.87	3.59	3.59	0.72	0.00
leiomyoma cell line:15242A	10570-108B3	47.83	8.15	1.09	4.35	3.80	0.54	0.00
leiomyoma cell line:15425	10571-108B4	59.98	7.53	1.46	4.13	0.97	1.21	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	107.94	31.75	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	64.82	8.36	3.14	1.05	3.14	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	27.04	8.85	0.47	0.94	0.47	0.12	0.00
liposarcoma cell line:KMLS-1	10782-110G8	50.30	6.87	0.94	2.34	1.72	0.62	0.00
liposarcoma cell line:SW 872	10726-110A6	43.25	8.29	2.92	1.83	0.85	1.10	0.00
liver, adult, pool1	10018-101C9	103.40	7.62	0.00	0.81	0.16	0.00	0.00
liver, fetal, pool1	10086-102B5	44.21	6.58	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	57.16	5.25	0.58	1.17	0.29	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	86.19	4.98	0.18	1.11	1.11	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	82.95	10.44	1.13	2.26	1.41	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	58.47	5.47	0.00	3.79	2.10	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	39.03	9.96	1.80	1.38	0.42	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	33.78	8.27	5.52	2.07	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	36.64	6.59	4.09	2.37	1.05	1.58	0.00
lung, adult, pool1	10019-101D1	69.22	6.14	0.35	1.42	0.59	0.24	0.24
lung, fetal, donor1	10068-101I5	77.35	10.56	0.00	0.57	1.43	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	51.32	4.12	0.46	0.00	0.00	0.00	0.00
lymph node, adult, donor1	10077-102A5	61.06	4.73	0.00	1.42	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	39.45	5.26	0.66	0.66	0.22	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	124.21	22.34	7.24	3.62	1.96	2.26	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	13.59	5.10	0.00	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	77.70	8.88	0.44	1.78	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	76.79	7.68	1.45	2.91	1.25	0.62	0.21
mature adipocyte, donor3	12233-129G1	75.39	6.16	1.19	4.27	0.24	0.47	0.24
mature adipocyte, donor4	12234-129G2	111.60	12.37	1.58	5.00	1.58	1.05	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	46.94	7.15	0.95	0.00	0.71	0.48	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	72.19	4.51	0.00	1.13	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	80.92	5.15	0.18	0.92	0.37	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	108.97	7.94	0.00	1.59	0.95	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	75.91	4.69	0.00	1.28	2.13	0.85	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	72.06	6.92	0.34	1.01	2.36	0.00	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	80.22	6.15	0.64	1.27	1.06	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	73.20	3.85	0.00	0.00	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	86.12	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	64.61	4.31	0.36	0.36	2.15	0.72	0.00
medulla oblongata - adult, donor10196	10174-103C3	74.63	6.49	0.00	1.30	1.95	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	76.47	6.19	0.31	1.24	0.31	0.00	0.15
medulla oblongata, adult, pool1	10038-101F2	70.36	7.67	0.24	1.14	1.14	0.16	0.00
medulla oblongata, newborn, donor10223	10361-105F1	65.27	6.60	0.35	1.04	0.35	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	23.91	8.86	2.44	2.88	1.11	0.89	0.00
medulloblastoma cell line:ONS-76	10759-110E3	16.26	5.99	2.45	1.47	1.10	0.61	0.00
melanoma cell line:COLO 679	10514-107E1	31.05	8.05	3.74	5.17	0.57	6.04	0.14
melanoma cell line:G-361	10465-106H6	15.47	9.23	4.89	10.32	2.99	1.36	0.00
meningioma cell line:HKBMM	10691-109F7	30.39	6.51	1.81	0.00	0.18	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	39.65	9.69	3.52	4.41	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	57.81	22.29	1.04	3.37	2.85	1.30	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	80.86	11.20	1.69	1.99	1.38	0.31	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	53.63	10.18	0.91	1.64	0.73	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	69.57	7.87	0.83	0.83	2.48	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	45.51	7.30	1.55	1.69	0.70	0.42	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	44.87	7.51	0.77	1.16	1.16	0.96	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	56.22	6.94	1.39	4.16	4.16	2.08	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	56.81	8.92	1.03	1.54	1.20	0.34	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	46.81	7.59	1.50	1.38	1.15	0.35	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	61.28	12.47	0.93	1.19	0.80	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	64.41	8.51	0.68	0.95	1.22	0.54	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	52.64	6.12	0.28	0.85	0.71	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	37.55	8.89	0.66	1.65	0.66	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	59.64	8.44	1.94	0.69	0.83	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	49.22	9.77	2.44	2.79	1.40	0.35	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	63.09	10.00	2.25	2.25	2.04	0.61	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	43.13	5.75	1.44	1.08	2.16	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	58.55	8.07	0.41	0.52	0.52	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.97	3.19	0.46	0.46	0.23	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	54.96	9.65	2.52	2.10	0.84	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	74.42	9.41	1.05	2.39	1.34	0.60	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	51.99	7.62	0.79	0.44	0.70	0.18	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	54.49	8.10	0.00	0.00	1.47	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	38.06	4.86	0.57	0.86	1.14	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	54.31	10.53	2.11	7.16	2.11	4.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	87.22	8.22	1.83	2.28	2.28	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	67.02	10.49	1.02	2.05	1.28	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	76.69	10.21	1.05	3.40	3.40	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	66.24	14.79	1.23	4.93	2.46	0.62	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	70.37	15.53	0.00	3.77	2.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	66.34	9.82	0.68	0.34	3.05	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	69.16	6.68	1.18	2.75	1.18	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	63.48	12.05	0.46	1.85	3.71	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	96.61	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	79.60	12.40	0.87	2.60	1.73	0.58	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	75.41	9.37	0.45	1.78	2.45	0.67	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	71.14	11.54	0.24	2.64	2.16	0.24	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	75.53	10.27	1.47	5.13	4.40	0.73	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	67.80	11.41	0.00	2.35	2.01	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	67.96	9.83	0.82	2.05	2.46	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	62.29	11.17	0.86	1.29	2.15	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	92.97	13.67	2.73	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	15.49	0.00	5.16	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	78.27	7.79	0.65	1.62	3.25	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	81.48	7.27	0.00	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	85.83	8.00	0.00	1.60	2.13	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	58.88	10.63	3.27	3.27	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	66.47	8.94	1.17	2.33	3.11	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	73.46	4.20	0.00	4.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	66.56	9.93	0.99	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	66.74	19.07	0.00	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	80.64	6.52	0.59	2.96	2.96	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	84.07	10.97	2.44	2.44	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	74.74	13.93	2.53	3.17	1.90	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	55.18	8.97	1.03	1.72	1.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	51.58	2.15	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	59.88	7.98	0.00	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	3.44	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	66.83	13.85	0.41	1.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	50.84	7.94	3.97	1.59	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	56.01	11.20	0.00	1.18	2.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	53.92	10.29	0.00	2.81	0.62	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	54.80	12.03	1.34	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	44.94	7.10	0.00	3.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	61.63	7.70	0.00	2.57	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	48.19	9.64	0.00	2.75	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	89.07	7.42	0.00	4.45	1.48	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	71.78	10.09	1.12	3.36	1.12	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	78.87	3.82	0.00	1.91	1.27	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	121.70	12.09	0.81	3.22	2.01	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	135.20	13.08	0.00	0.00	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	115.30	8.87	2.53	2.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	86.78	12.74	2.43	1.82	0.61	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	126.53	22.59	4.52	9.04	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	89.78	10.71	0.82	2.47	2.47	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	50.80	5.56	0.79	1.59	0.40	0.20	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	51.59	8.11	0.97	2.27	1.30	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	61.12	12.22	0.00	3.06	2.04	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	73.50	17.80	0.77	5.42	3.09	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	54.34	6.61	4.25	0.94	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.92	6.02	0.46	2.78	0.70	0.93	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	4.27	0.00	8.55	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	41.31	15.52	2.16	5.45	2.88	2.36	0.00
mesothelioma cell line:Mero-25	10850-111F4	26.33	11.57	2.04	2.27	0.91	0.45	0.00
mesothelioma cell line:Mero-41	10851-111F5	40.83	8.07	1.22	1.96	0.73	0.73	0.00
mesothelioma cell line:Mero-48a	10852-111F6	35.43	6.86	1.33	1.99	1.33	0.22	0.00
mesothelioma cell line:Mero-82	10853-111F7	32.06	7.62	1.84	1.31	1.05	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	21.62	5.11	1.19	1.36	0.34	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	33.87	11.37	2.02	3.29	1.52	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	34.16	5.80	1.24	1.66	0.62	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	33.46	6.63	2.98	2.15	1.82	0.99	0.17
mesothelioma cell line:NCI-H226	10846-111E9	30.23	6.15	1.09	5.07	1.81	1.45	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	36.04	9.91	2.22	1.37	2.56	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	42.24	3.05	0.25	2.04	1.27	0.76	0.00
mesothelioma cell line:No36	10857-111G2	35.56	7.50	1.63	1.63	1.63	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	23.03	2.98	0.54	1.35	0.81	0.27	0.00
migratory langerhans cells, donor1	11901-125F2	24.37	1.54	0.19	0.00	0.19	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	50.80	0.98	0.49	0.00	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	77.18	5.92	0.54	0.36	0.00	0.72	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	26.44	9.14	4.24	0.98	0.65	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	20.56	11.02	1.70	2.12	1.48	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	34.32	4.38	4.15	0.92	0.23	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	39.39	7.99	4.19	0.57	0.38	1.52	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	72.81	15.15	1.29	0.92	0.37	0.55	0.00
myeloma cell line:PCM6	10474-106I6	62.86	13.84	7.71	3.16	0.99	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	46.16	13.70	4.57	3.04	1.52	2.54	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	87.67	14.71	5.49	3.14	2.16	1.96	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.64	6.57	1.11	0.45	0.45	0.00	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	27.36	5.96	1.54	0.88	0.44	0.00	0.00
nasal epithelial cells, donor2	12227-129F4	25.94	6.07	0.55	0.55	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	42.10	11.73	3.22	1.38	0.69	0.23	0.00
neuroblastoma cell line:NB-1	10539-107G8	96.54	16.09	1.68	1.12	2.43	0.56	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	28.89	13.08	7.38	2.32	0.63	0.84	0.00
neuroblastoma cell line:NH-12	10555-107I6	38.20	19.75	2.42	3.91	2.61	0.19	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	76.39	37.96	2.61	10.91	3.32	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	71.27	30.57	2.38	9.34	3.80	2.53	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	25.36	22.54	2.01	4.63	2.62	0.20	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	41.96	16.53	2.54	2.54	1.91	0.64	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	40.19	7.72	0.80	1.86	1.06	0.80	0.27
neutrophil PMN, donor1	12133-128D9	163.62	29.75	44.62	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	757.00	53.12	13.28	26.56	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	653.47	104.18	0.00	18.94	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	13.53	3.72	4.40	0.34	0.34	0.51	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	237.75	27.22	8.01	1.60	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	56.11	18.27	0.32	1.92	1.28	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	53.08	13.40	0.79	1.58	2.36	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	80.71	7.59	0.19	1.12	0.66	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	98.90	6.18	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	97.15	6.71	0.00	0.00	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	62.60	5.46	0.00	0.36	0.73	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	119.39	11.81	0.00	2.10	2.10	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	100.84	12.87	0.00	1.29	2.57	0.00	0.00
occipital pole, adult, pool1	10036-101E9	73.95	6.31	0.32	0.55	0.47	0.08	0.00
olfactory region, adult	10195-103E6	94.19	7.45	0.96	1.34	1.15	0.00	0.00
optic nerve, donor1	10277-104E7	174.09	8.00	0.00	2.00	6.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	30.64	2.96	0.34	0.57	0.23	0.46	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	16.49	3.43	2.34	0.55	0.00	0.41	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	37.76	13.38	1.52	0.85	1.52	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	26.80	7.62	6.24	1.85	0.92	0.58	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	49.39	9.11	2.94	1.76	1.76	0.29	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	47.65	21.49	3.74	0.00	0.93	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	45.80	5.51	0.42	1.27	0.21	0.21	0.00
ovary, adult, pool1	10020-101D2	53.37	4.89	0.61	0.70	0.44	0.09	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	38.68	8.80	2.02	2.75	1.28	0.55	0.00
pancreas, adult, donor1	10049-101G4	61.14	2.82	0.00	0.94	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	15.93	10.62	3.91	1.96	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	26.58	10.56	1.70	2.56	1.36	1.02	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	36.10	3.97	1.32	0.33	0.33	0.99	0.00
paracentral gyrus, adult, pool1	10035-101E8	75.23	5.95	0.18	1.10	0.64	0.00	0.18
parietal cortex, adult, donor10258	10373-105G4	85.14	5.87	0.73	1.47	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	70.54	8.46	0.00	0.94	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	71.54	3.42	0.00	0.57	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	81.95	5.55	0.09	0.88	0.70	0.09	0.00
parietal lobe, fetal, donor1	10072-101I9	77.59	12.61	0.97	0.97	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	59.82	4.11	0.00	2.99	1.12	1.12	0.37
parotid gland, adult	10199-103F1	65.37	13.57	0.62	2.47	1.23	0.00	0.00
penis, adult	10200-103F2	66.06	6.45	0.00	4.30	0.54	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	32.91	9.30	2.23	2.05	1.30	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	33.36	9.18	3.64	0.29	0.44	1.02	0.00
pineal gland - adult, donor10196	10179-103C8	64.50	11.61	1.94	3.87	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	70.47	8.29	0.00	0.59	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	72.11	20.07	1.88	5.02	1.88	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	74.87	4.05	0.00	1.01	2.02	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	91.73	5.73	0.00	1.04	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	91.93	10.21	0.00	0.85	1.70	0.00	0.00
placenta, adult, pool1	10021-101D3	59.66	11.50	0.75	0.65	0.54	0.11	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	38.80	11.39	3.31	1.85	1.19	1.85	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	51.67	6.69	1.09	1.71	1.09	1.87	0.00
pons, adult, pool1	10033-101E6	57.23	7.66	0.09	1.29	0.95	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	85.34	5.67	0.17	0.70	0.61	0.09	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	48.10	0.00	8.37	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	198.29	33.05	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	305.13	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	57.54	12.67	9.47	4.22	0.87	3.20	0.00
prostate cancer cell line:PC-3	10439-106E7	36.84	6.72	4.54	2.36	1.82	0.91	0.00
prostate, adult, pool1	10022-101D4	67.47	5.71	0.54	1.27	0.45	0.09	0.00
putamen, adult, donor10196	10176-103C5	88.52	6.61	0.24	0.94	0.94	0.00	0.00
putamen, adult, donor10252	10152-102I8	188.23	5.88	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	55.73	8.74	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	91.57	7.01	0.24	0.97	0.72	0.48	0.00
putamen, newborn, donor10223	10365-105F5	44.98	7.50	0.00	1.50	2.25	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	22.40	8.73	1.75	0.58	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	59.81	11.13	1.39	1.39	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	36.25	9.12	3.60	5.94	0.21	3.39	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	30.65	2.07	3.31	1.24	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	81.71	9.14	2.19	2.88	1.79	2.29	0.10
retinoblastoma cell line:Y79	10475-106I7	42.87	10.13	7.53	1.30	1.30	1.82	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	16.97	13.16	3.32	2.83	2.34	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	54.83	19.97	6.75	3.66	1.97	1.69	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	65.18	19.70	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	22.82	3.72	0.00	0.16	0.32	0.00	0.00
salivary acinar cells, donor2	11772-123I8	34.15	6.20	0.83	1.79	0.69	0.28	0.00
salivary acinar cells, donor3	11773-123I9	45.68	1.99	1.32	1.32	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	77.21	11.44	1.14	0.00	1.14	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	33.89	10.54	2.95	3.37	1.35	1.60	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	37.62	10.58	2.70	4.70	1.53	3.76	0.12
seminal vesicle, adult	10201-103F3	59.26	7.41	0.53	1.06	1.06	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	43.97	7.53	3.40	3.16	2.92	1.94	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	48.82	6.29	1.51	1.01	1.26	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	61.22	21.07	2.01	3.01	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	44.33	12.76	1.48	2.96	1.48	0.81	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	73.39	10.83	8.62	2.76	0.88	4.20	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	97.29	12.64	9.68	2.06	1.42	2.84	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	178.75	20.57	1.42	0.71	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	193.94	17.63	0.24	0.96	0.96	0.12	0.12
skeletal muscle, fetal, donor1	10066-101I3	48.24	20.10	0.00	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	54.28	0.00	0.00	6.79	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	69.43	11.99	0.63	6.31	1.26	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	96.39	21.01	19.01	1.67	3.34	5.34	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	25.22	12.29	2.21	2.52	1.58	1.58	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	102.73	21.78	1.54	1.73	1.73	0.19	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	75.16	12.20	7.58	1.32	0.33	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	32.01	4.34	3.54	0.16	0.16	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	36.39	8.93	8.06	1.31	0.87	1.74	0.00
small intestine, adult, pool1	10024-101D6	175.58	6.69	1.43	0.84	0.84	0.48	0.00
small intestine, fetal, donor1	10064-101I1	86.24	6.14	0.74	1.97	0.98	0.74	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	54.88	9.23	5.64	2.05	0.51	2.05	0.00
smooth muscle, adult, pool1	10048-101G3	74.18	8.27	0.52	1.29	0.52	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	39.94	7.77	0.27	0.54	0.27	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	68.36	7.11	0.23	1.61	1.15	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	79.25	6.31	0.79	1.18	0.39	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	148.74	8.30	0.00	4.15	2.77	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	107.94	18.90	0.00	6.71	1.83	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	108.83	7.35	0.00	3.21	0.92	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	55.11	8.81	0.75	1.64	1.64	0.45	0.00
spleen, adult, pool1	10025-101D7	76.10	7.71	0.22	0.77	0.66	0.44	0.00
spleen, fetal, pool1	10044-101F8	54.82	6.91	0.95	1.03	0.40	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	35.92	7.25	3.52	1.04	1.04	1.45	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	28.67	12.15	1.90	0.57	0.57	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	45.43	20.97	3.84	3.49	2.10	0.70	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	38.31	7.43	3.52	0.39	0.39	1.17	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	61.68	5.63	1.69	0.56	0.45	0.23	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	27.96	14.40	4.24	1.27	2.12	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	29.61	4.65	2.96	0.85	0.42	0.42	0.00
stomach, fetal, donor1	10062-101H8	107.87	8.54	1.07	2.14	1.07	1.07	0.00
submaxillary gland, adult	10202-103F4	75.20	11.39	0.00	1.71	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	91.81	5.82	0.62	1.87	0.83	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	88.97	6.72	0.00	2.07	2.59	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	69.95	8.48	2.12	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	67.40	21.09	4.36	2.29	3.67	1.60	0.00
temporal lobe, adult, pool1	10031-101E4	94.77	6.87	0.08	1.36	0.51	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	91.88	10.68	0.00	1.42	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	88.35	10.11	0.00	0.88	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	65.98	10.47	0.35	2.09	3.84	0.35	0.35
tenocyte, donor2	11765-123I1	75.54	8.39	1.91	1.14	0.76	0.76	0.38
tenocyte, donor3	11768-123I4	70.06	8.53	1.48	1.48	0.74	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	12.92	11.05	2.55	4.93	2.04	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	34.38	15.41	3.08	1.85	1.39	1.39	0.00
teratocarcinoma cell line:PA-1	10807-111A6	26.19	18.91	2.79	4.18	1.39	0.77	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	28.06	18.92	2.16	3.94	2.16	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	10.59	15.13	3.78	7.19	0.76	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	12.76	11.23	1.74	2.29	0.55	0.22	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.89	16.29	2.61	1.63	1.30	0.00	0.00
testis, adult, pool1	10026-101D8	60.45	6.76	1.07	1.07	0.32	0.00	0.11
testis, adult, pool2	10096-102C6	43.76	5.86	1.80	0.90	1.35	0.45	0.00
thalamus - adult, donor10196	10168-103B6	79.49	6.62	0.00	0.00	2.21	0.00	0.00
thalamus, adult, donor10252	10154-103A1	95.18	9.22	0.63	0.63	0.78	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	127.79	7.70	0.00	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	61.10	5.76	0.33	1.15	1.32	0.16	0.00
thalamus, newborn, donor10223	10366-105F6	32.79	2.88	0.00	0.58	1.15	1.15	0.00
throat, adult	10209-103G2	84.14	8.74	0.50	1.75	1.25	0.25	0.00
throat, fetal, donor1	10061-101H7	65.82	12.19	1.83	2.74	1.22	0.30	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	67.17	11.33	1.19	2.38	1.99	0.79	0.00
thymus, adult, pool1	10027-101D9	81.72	10.14	2.39	0.30	0.50	0.40	0.00
thymus, fetal, pool1	10043-101F7	63.07	7.17	2.08	0.52	0.52	1.04	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	43.61	10.11	3.59	5.05	1.60	1.20	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	36.74	11.31	1.26	1.68	1.26	0.56	0.14
thyroid, adult, pool1	10028-101E1	101.71	7.47	0.09	0.93	0.37	0.00	0.00
thyroid, fetal, donor1	10060-101H6	65.39	5.80	0.26	1.32	1.32	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	36.96	6.16	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	64.19	9.30	2.56	0.23	1.40	0.23	0.00
tongue, fetal, donor1	10059-101H5	113.10	12.61	0.39	1.97	0.79	0.39	0.00
tonsil, adult, pool1	10047-101G2	61.61	7.61	2.40	0.50	0.50	0.30	0.00
trachea, adult, pool1	10029-101E2	69.12	6.30	0.90	0.74	0.33	0.08	0.00
trachea, fetal, donor1	10058-101H4	45.39	5.39	0.77	2.31	0.00	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	49.60	8.15	1.06	2.83	1.42	1.42	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	27.56	7.19	1.72	1.01	0.61	0.51	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	37.13	9.24	6.42	3.76	0.47	1.88	0.00
tridermal teratoma cell line:HGRT	10694-109G1	60.88	17.12	1.90	3.81	1.90	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	111.06	16.00	2.20	2.03	2.03	0.17	0.00
umbilical cord, fetal, donor1	10057-101H3	39.64	8.35	0.00	2.09	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	73.37	5.63	0.68	0.51	0.68	0.17	0.00
uterus, fetal, donor1	10055-101H1	50.17	12.80	1.54	1.02	1.02	0.00	0.00
vagina, adult	10204-103F6	36.19	5.17	0.00	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	53.48	8.33	0.66	1.53	0.44	0.44	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	29.37	8.55	3.74	0.53	0.27	0.53	0.00